Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010

Publication date: 2011

Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 . ACKNOWLEDGEMENTS UNFPA is grateful for the valuable contributions made to this report by staff and partners, and for the active engagement and support of the donors and agencies that made this report possible. The report has also benefitted significantly from the guiding efforts of Jagdish Upadhyay, Chief of UNFPA’s Commodity Security Branch. Also within the branch, special thanks goes to Dr. Kabir Ahmed, Technical Adviser, and Dr. Sukanta Sarker, Technical Specialist, for coordinating with donors and other stakeholders to collect, compile and clean data and for authoring this report. The writers would like to thank Asmeret Tekeste and colleagues in the Commodity Security Branch for their support. For more information, visit: www.unfpa.org Commodity Security Branch United Nations Population Fund 605 Third Avenue New York, NY 10158 USA August 2011 CONTENTS INTRODUCTION . i EXECUTIVE SUMMARY . iv BACKGROUND . vi Findings A. GLOBAL PATTERNS AND TRENDS IN DONOR SUPPORT .1 Trend analysis . 3 Couple years of protection (CYP) . 6 B. DONOR SUPPORT IN 2010 .9 UK Department for International Development (DFID) . 9 International Planned Parenthood Federation (IPPF) . 9 Federal German Ministry for Economic Cooperation and Development (BMZ/KfW) . 11 Marie Stopes International (MSI) . 12 Population Services International (PSI) . 13 United Nations Population Fund (UNFPA) . 14 United States Agency for International Development (USAID) . 17 C. DONOR SUPPORT FOR MALE AND FEMALE CONDOMS . 20 Condom requirements . 20 Patterns and trends in donor support for condoms versus other contraceptives . 20 D. COMPARISON OF CONTRACEPTIVE NEEDS AND DONOR SUPPORT . 24 Unmet need . 25 Standard costs . 25 Varying degrees of donor dependency . 25 Linking donor support to CPR . 25 Annex 1: Donor support 2010 at a Glance . 26 Annex 2: Commodities: Donors’ Contribution . 31 Annex 3: Country Tables: Donors, Commodities and Values………………………………………………. 34 Figures Figure 1: Commodity expenditure (%) 2010 Figure 2: Trends in major donor support for commodities, 2005–2010 Figure 3: Regional distribution of donor support, 2005–2010 Figure 4: Trend in donor expenditure by commodities, 2005–2010 Figure 5: Cost per CYP, 2005-2010 Figure 6: Values and CYPs, 2005–2010 Figure 7: Distribution of short- and long-acting methods in CYP, 2005–2010 Figure 8: Expenditure on condoms and other contraceptives, 2005–2010 Figure 9: Proportion of expenditure: Condoms and other contraceptives, 2005–2010 Figure 10: Expenditure trend of male and female condoms, 2005–2010 Figure 11: Donor expenditure of male condoms, 2005–2010 Figure 12: Donor expenditure of female condoms, 2007–2010 Figure 13: Projected contraceptive need Figure 14: Commodity Expenditure (%) 2010 Figure 15: Quantity of Male Condom Supplied by Donors (%) 2010 Figure 16: Quantity of Female Condom Supplied by Donors (%) 2010 Figure 17: Quantity of Oral Pills (Low dose & Progesteron only) Supplied by Donors (%) 2010 Figure 18: Quantity of Emergency Contraceptives Supplied by Donors (%) 2010 Figure 19: Quantity of Injectables Supplied by Donors (%) 2010 Figure 20: Quantity of IUD Supplied by Donors (%) 2010 Figure 21: Quantity of Implant Supplied by Donors (%) 2010 Tables Table 1: Donor support in 2010 Table 2: Comparison of expenditure (in US$) between 2009 and 2010 Table 3: Quantity and value of commodities in 2010 Table 4: Regional distribution of commodities, 2010 Table 5: Comparison of commodity quantity, 2009 and 2010 Table 6: CYP by commodity, 2005–2010 Table 7: Support of DFID, 2010 Table 8: Regional distribution of IPPF resources Table 9: Support of IPPF, 2010 Table 10: Regional distribution of BMZ/KfW support Table 11: Support of BMZ/KfW, 2010 Table 12: Regional distribution of MSI, 2010 Table 13: Support of MSI, 2010 Table 14: Regional distribution of PSI, 2010 Table 15: Support of PSI, 2010 Table 16: Regional distribution of UNFPA support, 2010 Table 17: Support of UNFPA, 2010 Table 18: Regional distribution of male and female condoms by UNFPA, 2010 Table 19: Regional distribution of USAID, 2010 Table 20: Support of USAID, 2010 Table 21: Regional distribution of male and female condoms, USAID 2010 Table 22: Donor Support, 2010 Table 23: Male Condom Table 24: Female Condom Table 25: Oral Contraceptives Table 26: Emergency Contraceptive Pills Table 27: Injectable Contraceptives Table 28: Intra Uterine Device Table 29: Sub-dermal Implants Table 30: Quantity & Value of Commodities in 2010 Table 31: Regional Distribution of Commodities (Quantities) Table 32: Comparison of Expenditure in US$, 2009-2010 Table 33: Comparison of Commodity Quantity Table 34: Expenditure Trend by Donor in US$, 2005-2010 Table 35: Expenditure Trend by Region in US$, 2005-2010 Table 36: Method-wise Expenditure Trend in US$, 2005-2010 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 i INTRODUCTION I. About the report UNFPA, the United Nations Population Fund, has been tracking donor support for contraceptives and condoms for STI/HIV prevention since 1990 and publishing an annual donor support report since 1997. These annual reports are produced by the Commodity Security Branch in UNFPA’s Technical Division, which is pleased to present the 2010 Donor Support report. This report highlights trends in support from bi-lateral and multi-lateral donors as well as social marketing organizations. In addition, the report provides information on donor support for essential reproductive health (RH) commodities, including contraceptives and condoms, for reproductive health programmes in developing countries. Data is presented and analyzed by region, major donor and contraceptive methods. There is also a section on donor support for male and female condoms. The report covers (1) family planning supplies and (2) condoms for the prevention of sexually transmitted infections (STIs), including HIV. It does not cover any reproductive health commodities required for maternal health services such as prenatal care, obstetric services, postpartum care or abortion-related services, nor does it cover supplies required for the diagnosis and treatment of STIs including HIV. The report has four main sections: 1. The first and second sections examine patterns and trends in individual donor support in 2010 as well as from 2005-2010. Trends are analyzed in terms of expenditures, quantities and approximated couple years of protection. These trends are then analyzed by several major variables—or combination of variables—such as distributions by commodity type, individual donor governments/agencies and regions; 2. The third section takes a closer look at donor support for male and female condoms over time and by region; 3. The fourth section compares aggregate donor support to global contraceptive needs for 2006- 2010 and provides projections of contraceptive needs through 2015. Purpose of report This report provides data for development – the kind of data that makes a difference and drives good planning and decision making. This data can be used on behalf of the women, men and young people in developing countries who count on contraceptives and condoms to plan and space their families and prevent sexually transmitted infections, including HIV. Ultimately, this data supports the right to enjoy a life of health and equal opportunity. The report is intended mainly for use in planning for contraceptive supply, advocacy and resource mobilization. In addition, the report has a ‘value added’ impact on issues related to Reproductive Health Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 ii Commodity Security (RHCS) in areas such as policy dialogue, advocacy and interagency work. UNFPA hopes that, among its many potential benefits, this annual report can help to enhance coordination among donors, improve partnerships between donors and national governments, and mobilize the resources needed to accelerate progress towards universal access to sexual and reproductive health, as set forth in the ICPD Programme of Action and the Millennium Development Goals. Global Donor Support Database The primary source of data for this report is UNFPA’s Global Donor Support Database. As the lead United Nations agency in the area of sexual and reproductive health, UNFPA is charged with tracking international financial support in this area. Since, 1990 the database – the largest of its kind – has tracked more than 20,000 procurement records of contraceptives, condoms for STI/HIV prevention and other types of related RH commodities by major bilateral, multilateral and NGOs. The database records the financing organization and recipient country, and also the commodity type, quantity and expenditure. UNFPA actively solicits relevant data from major donors on an annual basis; the database itself is updated continuously based on the latest information. (N.B. This database does not capture private sector, country procurements or procurements financed by the Global Fund or World Bank.) To make this database useful to a wider audience, UNFPA summarizes and analyzes the data for the benefit of donors, national governments and other partners. A few caveats should be noted The 2010 Donor Support report includes the latest year for which data is available, and it also updates data from previous years where new information is available. Consequently, data prior to 2010 may differ from that which appears in previous years’ reports.  This report tracks donor support, not the entire universe of global commodity procurement. Most commodities procured directly by countries, for example, are not included. This is particularly the case for large, middle-income countries such as Brazil and China. The database currently does not include data from the Global Fund. World Bank contraceptive financing is not included since these are loans provided for contraceptive procurement.  While UNFPA makes every effort to obtain comprehensive, reliable and current data, some errors in reporting and maintaining such a large database inevitably occur. UNFPA reviews records to ensure accuracy, making modifications where possible when errors are evident. Such errors and adjustments occur infrequently in the database and should not have a large influence on the outcomes of this report’s analyses.  The data in this report pertain to the supply of commodities, not ultimate utilization. A variety of factors can affect rates of commodity utilization by end users.  Finally, it should be remembered that certain commodities covered by this report are utilized for purposes in addition to, or other than, contraception. Male and female condoms, for example, are mostly procured and utilized for STI/HIV prevention. This report does not distinguish between the dual purposes of condom use. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 iii Process of producing the report All donors/partner are requested to send their respective 2010 data for the report before the end of the first quarter of 2011. UNFPA produces an updated report every year upon receipt and analysis of the necessary data from participating organizations. The data consist of the following pieces of information: 1. name of the country to which commodities were sent; 2. type of contraceptives sent, e.g. pills, injectables, IUD, condoms (male and female); 3. unit price (price by units related to number 4 below); 4. total quantity (for the quantity, the unit is specified, e.g. cycles of pills, number of condoms, number of IUDs, number of injection vials, etc.); 5. total amount spent in 2010. Once the data are received, the process by the Commodity Security Branch in UNFPA’s Technical Division consists of the following steps: 1. review the data provided to check any quality issues as well as any double counting between different data providers; 2. send a spreadsheet back to each data provider following the review, highlighting any issues identified and request for data validation to allow to proceed for finalizing the report; 3. establish a final data set once the data has been validated by all data providers; 4. produce a final draft report and send back to all for feedbacks and inputs; 5. incorporate all relevant inputs, prepare the final report and disseminate electronically as well as post in the UNFPA website. Geographical distribution For this report the countries have been grouped into four regions. Almost all African countries were included in the African region. However, some of the Northern African countries were included in Arab States. Arab States includes Egypt, Morocco and Yemen as well as countries from the Middle East, Eastern Europe and Central Asia, as well as Ukraine from Eastern Europe. Countries from Asia and Pacific Island countries were included in the Asia and Pacific region. Latin American countries and countries from Caribbean are grouped as the Latin American region. Unit of measurement In this report unit of measurement is reported for male and female condom as ‘piece’, all kinds of pills as ‘cycles’, emergency contraception as ‘pack’, injectable as ‘vial’, IUD as ‘piece’ and implant as ‘set’. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 iv EXECUTIVE SUMMARY Access to a reliable supply of contraceptives, condoms and other reproductive health commodities is essential to all UNFPA programming and to achievement of the Millennium Development Goals. The need for voluntary family planning is growing fast, and condom use is a critical element in a comprehensive approach to HIV prevention and treatment. Each year, UNFPA looks at the level of support provided by donors for selected reproductive health commodities. In 2010, donors including BMZ/KfW, DFID, IPPF & MSI, PSI, UNFPA and USAID provided $235.6 million to support the procurement of male and female condoms, oral contraceptives, emergency contraceptive, injectables and IUDs in 143 developing countries. Highlights of the report Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2010 include the following: Total donor support  Donors provided $235.16 million in 2010, a slight decrease of 1.5 per cent from $238.8 million in 2009;  About two thirds of total donor support came from UNFPA 1 (35 per cent) and USAID (32.2 per cent). From 2009 to 2010, UNFPA’s contribution increased by $1.2 million to $82.3 million, while USAID’s contribution decreased by $11.5 million to $76 million.  A number of donors increased support over the previous year, notably BMZ/KfW and PSI, and also DFID and UNFPA. Support from IPPF, MSI and USAID decreased.  Bilateral funding accounted for 51.7 per cent of total donor support in 2010. Another 34.7 per cent was channeled through UNFPA and 12.9 per cent through social marketing organizations; Support by region  Most support continued to be directed to sub-Saharan Africa, followed by Asia and the Pacific. Of total donor support in 2010, sub-Saharan Africa received 63 per cent, Asia and the Pacific region received 25 per cent, Latin America and the Caribbean received 7 per cent and the Arab States received 4 per cent.  Increases in support occurred in two regions in 2010. Donor support to Asia and the Pacific increased by 60 per cent in 2010 compared to 2009, and support to the Arab States increased by 1.7 percent. Decreases in support affected two regions. Support to sub-Saharan Africa was 15 per cent lower in 2010 than in 2009, and support to Latin America and the Caribbean was down by 7 per cent. Data collected 2005-2010 shows no pattern in regional trends in donor support, although totals vary year to year.  Asia and the Pacific Region received $22.3 million more than in the previous years, up from $37.2 million in 2009 to $59.5 million in 2010. 1 UNFPA data includes third party procurement 2 Reproductive Health Supplies Coalition, Contraceptive Projections and the Donor Gap: Meeting the Challenge 2009. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 v  Sub-Saharan Africa received $25.4 million less than in the previous year, down from $173.1 million in 2009 to $147.6 million in 2010. Support by commodity  More than 77 per cent of donor support in 2010 was allocated to three types of commodities: male condoms (32 per cent), injectables (24 per cent) and oral contraceptives (21 per cent).  Donors provided less support in 2010 than in 2009 for three contraceptives methods, with a decrease of 51 per cent for female condoms, 31 per cent for emergency contraceptives, and 17.5 per cent for implants.  Donors provided more support for IUDs, with an increase of nearly 14 per cent from 2009 to 2010. Despite the increase, the IUD accounted for only 1.32 per cent of total expenditures in 2010. The IUD provided nearly 25 million contraceptive years of protection (CYP) in 2010.  Like previous years, the highest expenditure in 2010 was on condoms. Expenditure on both male and female condoms together was 37 per cent of total donor support; followed by 24 per cent on injectables and 22 per cent on oral contraceptives (combined oral pills and emergency contraceptive pills).  In 2010, the cost of commodities required to provide one CYP was $3.32. Data collected over six years shows that cost was lowest in 2005 ($2.27 per CYP) and highest in 2006 ($4.66 per CYP). This cost is largely influenced by the IUD. In 2005, nearly 15.5 million IUDs (pieces) were procured, providing some 55 million CYP. In 2006, only 2.5 million IUD pieces were procured, providing only 9 million couple years of protection. Despite difficult economic times, donor support for contraceptives and condoms remained strong, with only a slight decrease from 2009 to 2010. The future is the challenge. To meet current population growth rates, donor funding for contraceptives will need to increase by 60 per cent, from about $230 million per year today to about $370 million by 2020, or by more than 80 per cent to more than $420 million by 2020 to eliminate unmet need. 2 2 Reproductive Health Supplies Coalition, Contraceptive Projections and the Donor Gap: Meeting the Challenge 2009. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 vi BACKGROUND The reproductive health context The goal of universal access to reproductive health services was first put forth in the Programme of Action adopted at the International Conference on Population and Development (ICPD) held in Cairo in 1994. This goal was reinforced in 2007 when the General Assembly of the United Nations added universal access to reproductive health—to be achieved by 2015—to the Millennium Development Goals (MDGs). Contraceptive prevalence and unmet need for contraception were added to the MDGs indicator framework to measure progress in the coming years. Ensuring that reproductive health commodities are available to all who need them is essential to the provision of reproductive health services/family planning and thus to the achievement of the ICPD and MDGs. Together with family planning, maternal health services and STI/HIV diagnosis and treatment have a tremendous impact on the welfare of a society, with benefits going far beyond the medical benefits of averting death and morbidity and improving child survival. Improved reproductive health in a country also strengthens the position of women and contributes to economic growth. Maternal health More than 100 countries worldwide have eliminated or nearly eliminated maternal mortality as a public health problem. In spite of this, there are still approximately 350,000 maternal deaths and over 1 million newborn deaths yearly in the world. For every woman who dies in childbirth, at least 20 more suffer injuries, infections or disabilities. The vast majority of these deaths occur in sub-Saharan Africa and southern Asia. 3 In sub-Saharan Africa, a woman’s risk of dying from such complications over the course of her lifetime is 1 in 22 compared to 1 in 7,300 in the developed world. 4 This reality could be averted with highly cost-effective and feasible interventions. UNFPA promotes a three-pronged strategy:  All women have access to contraception to avoid unintended pregnancies  All pregnant women have access to skilled care at the time of birth  All those with complications have timely access to quality emergency obstetric care When interventions, including family planning, are adopted and scaled up with a rights-based and equity-driven approach, rapid progress is possible. Voluntary family planning Family planning is a powerful tool in combating poverty. However, universal access to family planning it is not yet a reality – particularly not among the poorest. Worldwide, 200 million women would like to delay or prevent pregnancy, but are not using effective contraception. The demand for contraceptives is expected to grow by 40 per cent in the next 15 years. 3 WHO, UNICEF, UNFPA, World Bank 2005. Maternal Mortality in 2005. 4 The Millennium Development Goals Report 2008 (MDG Report 2008). Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 vii Family planning saves lives. It reduces maternal and newborn mortality rates and improves the health and well-being of women and their existing children. Estimates have indicated that, by preventing pregnancies and unsafe abortions, reliable access to quality family planning services and information can reduce maternal deaths by one third, which equates to saving the lives of 100,000 to 175,000 women each year. Family planning programmes create conditions that enable women to enter the labour force and families to devote more resources to each child, thereby improving family nutrition, education levels and living standards. Slower population growth cuts the cost of social services as fewer women die in childbirth; and demand eases for water, food, education, health care, housing, transportation and jobs. Comprehensive condom programming Condoms, both male and female, are recognized as the only currently available and effective technology to prevent HIV – and other sexually transmitted infections – among sexually active people. The goal of condom programming is to reduce the number of unprotected sex acts, which will, in turn, reduce the incidence of unintended pregnancy and sexually transmitted infections. Comprehensive condom programming works towards that goal through promotion, communication for behavior change, optimized use of entry points like RH clinics, and management of supplies, among other strategies. An estimated 13 billion condoms per year are needed to help halt the spread of HIV and other sexually transmitted infections, according to UNAIDS. For many other developing countries, the gap between condom needs and donor support means paying for imported condoms with funds needed for food, medicine and other necessities. The role of reproductive health commodities Effective strategies to achieve global reproductive health goals will require integrated, country-driven approaches that include: (1) expanded reach and quality of affordable reproductive health services in the context of overall health systems strengthening; (2) improved capacity to plan, implement and monitor and evaluate at country level; (3) increased government and international financial and technical resources; (4) enhanced coordination within the donor community; and (5) advocacy and changes in attitudes that prevent women and girls from exercising their reproductive health choices. One of the critical components underpinning any strategy is the availability of affordable, quality RH commodities to all individuals who need them. Availability of and access to RH commodities are not only basic human rights, as established in the ICPD and MDG frameworks, but are also critical to improving related health outcomes, such as maternal health and HIV prevention. RH commodities play integral roles not only before pregnancy but also during pregnancy and childbirth. Most antenatal services, delivery and post-partum care and emergency obstetric care could not be delivered effectively and safely without appropriate RH commodities in the right place and at the right time. Availability of and access to RH commodities (contraceptive, condoms, medicine and equipment) are critical to improving health outcomes in maternal health and STI/HIV prevention and to allowing individuals to plan the size of their families. RH commodities, including HIV test kits and diagnostics, are critical for successful HIV prevention strategies and programmes—and so are male and female condoms, Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 viii which can reduce risk of STIs, including HIV. It is for these reasons that UNFPA and other agencies are committed to working with governments to prioritize gender and sexual and reproductive health in response to HIV and AIDS, and making contraceptives available to all who need them to space or limit the number of children they will have. Funding is needed for more than commodities This report covers only a subset of reproductive health commodities: family planning supplies and condoms for STI/HIV prevention, as noted above. It does not cover any commodities required for maternal health services such as prenatal care, obstetric services, postpartum care, and abortion-related services, nor does it cover supplies required for the diagnosis and treatment of sexually transmitted infections (STIs), including HIV. Investing in the commodities required in those areas is just as crucial as investing in contraceptives and condoms. Commodities themselves constitute only a small portion of what is needed. To improve reproductive health and reach the goal of universal access, countries need to ensure that investments in supplies will complement large investments targeted at strengthening supply chains and service delivery systems as well as information, education and communication activities. The development of capacity in health systems is an important aspect reproductive health commodity security. So too is the provision of essential RH supplies including the contraceptives and condoms featured in this report. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 1 A. GLOBAL PATTERNS AND TRENDS IN DONOR SUPPORT The total donor support in 2010 was just over $235 million (Table 1), which was 3.6 million (1.5 per cent per cent) less than the total of $238.8 million in 2009. Contributions from different donors changed from the previous year. UNFPA’s contribution was the highest at just over $82 million (35 per cent of total support), followed by USAID at $76 million (32 per cent of total support) (Table 2). Figure 1 shows donor contributions in 2010 by percentage. The largest increase in contributions was by BMZ/KfW, which increased more than 80 per cent from $16.1 million in 2009 to $29.1 million in 2010. This was followed by PSI, with an increase in contributions of nearly 50 per cent from $17.9 million to $26.9 million. DFID’s contribution increased by 27.57 per cent. UNFPA’s contribution increased by 1.5 per cent. IPPF and MSI contributions decreased by a combined 82 per cent, and USAID’s contribution declined by 13 per cent. 7.06 1.01 12.41 0.73 11.44 35.04 32.32 Figure 1: Commodity expenditure (%) 2010 DFID IPPF KFW MSI PSI UNFPA USAID Total: $235.16m Table 1: Donor support in 2010 Donors Amount (US$) Percentage DFID 16,590,831 7.06 IPPF 2,367,315 1.01 BMZ/KfW 29,180,788 12.41 MSI 1,708,477 0.73 PSI 26,909,321 11.44 UNFPA 82,391,543 35.04 USAID 76,014,739 32.32 Total 235,163,014 100 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 2 Table 2: Comparison of expenditure (in US$) between 2009 and 2010 2009 2010 Comparison 2009-2010 Change Percentage DFID 13,005,195 16,590,831 3,585,636 27.57 BMZ/KfW 16,189,032 29,180,788 12,991,756 80.25 PSI 17,942,658 26,909,321 8,966,663 49.97 UNFPA 81,136,535 82,391,543 1,255,008 1.55 USAID 87,549,507 76,014,739 (11,534,768) -13.18 IPPF & MSI 22,977,954 4,075,792 (18,902,162) -82.26 Total 238,800,882 235,163,014 (3,637,868) -1.52 Like previous years, the highest expenditure in 2010 was on condoms (Table 3). Expenditure on both male and female condoms together was 37 per cent; followed by 24 per cent on injectables and more than 22 per cent on oral contraceptives (combined oral pills and emergency contraceptive pills). Table 3: Quantity and value of commodities in 2010 Methods Quantity Value Percentage of total value Male condoms 2,797,251,012 76,090,517 32.36 Female condoms 18,405,464 11,344,582 4.82 Oral contraceptives 161,882,534 51,171,091 21.76 Emergency contraceptive 3,262,617 1,207,429 0.51 Injectables 89,683,629 56,960,511 24.22 IUDs 7,118,425 3,103,107 1.32 Implants 1,561,545 32,984,272 14.03 Other* 2,301,505 0.98 Total 235,163,014 100 * sampling, testing of condoms, art work In 2010, Africa received commodities valued at more than $147 million, which was approximately 63 per cent of the total (Table 4). The next recipient region was Asia with nearly $59 million (25 per cent). The Arab States region received 4.46 per cent and the Latin America region 7 per cent. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 3 Table 4: Regional distribution of commodities, 2010 Regions Amount (US$) Percentage Africa 147,670,950 62.80 Asia and Pacific Islands 59,338,695 25.23 Arab States 10,495,041 4.46 Latin America and Caribbean 16,621,266 7.07 Others * 1,037,062 0.44 Total* 235,163,014 100 * IPPF had commodities worth $442,623 on hand and could not distribute them to the countries by the end of December. UNFPA provided $594,438 worth of commodities to an organization, and regional distribution of those commodities are not yet available. So, in total, $1,037,062 was not included in regional distribution but listed as ‘others’. Table 5 shows a comparison of commodity support between 2009 and 2010. The highest increase was an increase in support for IUDs (13.95 per cent) and injectables (13.19 per cent), followed by oral contraceptives (10.85 per cent) and then male condoms (2.79 per cent). The largest decrease was in support for female condoms (more than 51 per cent), followed by emergency contraceptives (31.43 per cent) and implants (17.55 per cent). Table 5: Comparison of commodity quantity, 2009 and 2010 2009 2010 Change in percentage Male Condoms 2,721,195,550 2,797,251,012 2.79 Female Condoms 37,842,502 18,405,464 (51.36) Oral Contraceptives 146,031,399 161,882,534 10.85 Emergency Contraceptive 4,758,270 3,262,617 (31.43) Injectables 79,235,645 89,683,629 13.19 IUDs 6,247,021 7,118,425 13.95 Implants 1,893,894 1,561,545 (17.55) Trend analysis Figure 2 shows the trend of major donors’ support from 2005 to 2010. UNFPA and USAID are the two major donors but contribution of other donors is also substantial. The figure does not show any pattern of support over the past six years. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 4 Figure 2: Trends in major donor support for commodities, 2005–2010 Figure 3 shows the regional trend in donor support from 2005–2010. Throughout this time period, Africa has been the highest recipient of support, followed by Asia. For Africa, support decreased slightly from 2005 to 2006, increased through 2009 and then, in 2010, support to Africa decreased substantially. It declined from $173 million in 2009 to $147 million in 2010 – down by some $25 million. Support to the Asia region started to decline from 2006 to 2009, and then in 2010 it increased from $37 million to nearly $59 million, an increase of $22 million. The countries in the region of the Arab States, Middle Eastern countries, Eastern Europe and Central Asia received the lowest levels of funding during all these years. This region received approximately $10.31 million in 2009 and the amount increased slightly to $10.49 million in 2010. The Latin American region has been consistent in securing donor support over the last several years ranging from $16 million to $20 million, in spite of slight decrease in 2010. Detailed figures are available in the tables of Annex 1. $0 $10 $20 $30 $40 $50 $60 $70 $80 $90 $100 DFID KFW PSI UNFPA USAID IPPF & MSI M il li o n s 2005 2006 2007 2008 2009 2010 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 5 Figure 3: Regional distribution of donor support, 2005–2010 Figure 4 summarizes expenditure trends for commodities from 2005 to 2010. Donor expenditure slightly increased from 2005 to 2006; and then increased by 7 per cent in 2007 but it dropped by more than 4 per cent in 2008 and then increased by nearly 12 per cent in 2009. However, in 2010 support decreased by 1.5 per cent. Figure 4: Trend in donor expenditure by commodities, 2005–2010 The largest expenditure has been for male condoms, with an increase of 5 per cent from $72.6 million in 2009 to $76 million in 2010. Donor support for female condoms doubled from 2008 to 2009, but it decreased sharply from $29 million in 2009 to $11.3 million in 2010. There has been a substantial $0 $20 $40 $60 $80 $100 $120 $140 $160 $180 $200 2005 2006 2007 2008 2009 2010 M il li o n s Africa Asia & Pacific Arab States Latin America & Caribbean $0 $50 $100 $150 $200 $250 $300 2005 2006 2007 2008 2009 2010 M il li o n s Male Condoms Female Condoms Oral Contraceptives Injectables IUDs Implants Other* Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 6 increase in oral contraceptives (14 per cent) and injectables (8 per cent), while expenditures for IUDs and implants decreased slightly. Figures in Annex 2 illustrate the quantities of contraceptives including condoms provided by donors in 2010. UNFPA and USAID were the largest suppliers of male condoms (30 per cent and 26.5 per cent respectively). For female condoms, UNFPA’s contribution was nearly 54 per cent, followed by USAID at 31 per cent. PSI also made a substantial contribution to female condoms, at nearly 16 per cent. Again, UNFPA and USAID combined contributed nearly 50 per cent of oral contraceptives (approximately 24 per cent each). UNFPA was the largest supplier of implants (nearly 66 per cent), IUDs (65 per cent), injectables (nearly 59 per cent) and female condoms (53.5 per cent). Couple years of protection (CYP) Condoms are used for both for contraception and prevention of sexually transmitted infections, including HIV. In a study in 132 low- and middle-income countries, it was estimated that approximately 30 per cent of condoms, both male and female, are required to meet family planning needs. 5 Table 6: CYP by commodity, 2005–2010 CYP '05 CYP '06 CYP '07 CYP '08 CYP '09 CYP '10 Male Condom (FP) 6,114,308 5,588,278 8,071,223 5,901,258 6,802,989 6,993,128 Female Condom (FP) 17,543 33,534 41,120 45,473 94,606 46,014 Oral Contraceptive 13,488,820 11,910,886 12,812,580 15,559,921 9,735,427 10,792,169 Emergency Contraceptive 203,255 335,313 152,640 655,027 317,218 217,508 Injectable 16,772,305 16,921,649 17,431,727 23,612,963 19,808,911 22,420,907 IUD 53,995,732 8,999,648 19,130,341 9,953,993 21,864,574 24,914,488 Implant 759,731 1,003,457 3,016,622 3,693,704 6,628,629 5,465,408 Total CYP 91,351,694 44,792,766 60,656,252 59,422,339 65,252,353 70,849,620 In 2010, the total contributed by all methods was nearly 71 million couple years of protection. This represents an increase of 8.5 per cent in CYP from 2009 (Table 6). IUDs and injectables each contributed one third of the total CYP. The contribution of oral contraceptives was about 15 per cent and for male condoms was less than 10 per cent. Although implants accounted for 14 per cent of total expenditures, they contributed only 7.7 per cent of the total CYP. 5 Contraceptive Projections and the Donor Gap: Meeting the Challenge, Reproductive Health Supplies Coalition, 2009 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 7 Figure 5 shows that $3.32 was required for commodities to provide one couple year of protection. The graph also shows that cost was lowest in 2005, when $2.27 was spent to provide one CYP, and it was highest in 2006 when $4.66 was spent to provide one CYP. The data revealed that in 2005 nearly 15.5 million IUDs (pieces) were procured, providing nearly 55 million couple years of protection. In contrast, in 2006 only 2.5 million IUD pieces were procured, providing only 9 million couple years of protection. Figure 6 shows total expenditure and estimated CYP from 2005 to 2010. The total couple years of protection provided in 2010 was 71 million. The graph also shows that approximately 91 million CYP were provided with a cost of approximately $207.5 million in 2005. About $1 million more was spent to procure commodities in 2006 than in 2005, but less than half the number of couple years of protection were provided in that year than in the previous year. 2.27 4.66 3.68 3.60 3.66 3.32 $0 $1 $2 $3 $4 $5 2005 2006 2007 2008 2009 2010 Figure 5: Cost per CYP, 2005-2010 208 209 223 214 239 235 91 45 61 59 65 71 - 50 100 150 200 250 300 2005 2006 2007 2008 2009 2010 M il li o n s Figure 6: Values and CYPs, 2005–2010 Value CYPs Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 8 Figure 7 gives a comparison of short- and long-acting methods of contraception for the last six years. The effect of procurement of a high number of IUDs in 2005 had an impact on the proportion of short- and long-acting methods in that year. In 2008, the gap between short- and long-acting methods was very large; in that year, expenditure on IUDs decreased. In 2009 and 2010, expenditure for short- and long-acting methods was more consistent. - 10 20 30 40 50 60 2005 2006 2007 2008 2009 2010 M il li o n s Figure 7: Distribution of short- and long-acting methods in CYP, 2005–2010 Short Acting Methods Long Acting Methods Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 9 B. DONOR SUPPORT IN 2010 UK Department for International Development (DFID) Contraceptive support by DFID in 2010 was more than $16.5 million. Male condom support was the highest at more than $10 million, which constituted nearly 62 per cent of total support, followed by injectables (19.78 per cent), oral contraceptives (15.22 per cent) and implants (nearly 3 per cent). Female condom support amounted to 5,000 pieces (Table 7). DFID support for male and female condoms, oral contraceptives and implants went to five African countries (Angola, Kenya, Nigeria, Uganda and Zimbabwe) and to China in Asia. Table 7: Support of DFID, 2010 Methods Quantity Value (US$) Percentage of total value Male Condom 449,091,810 10,283,152 61.98 Female Condom 5,000 3,300 0.02 Oral Contraceptives 9,580,400 2,525,795 15.22 Injectables 3,508,000 3,282,265 19.78 Implants 20,600 496,319 2.99 Total 16,590,831 100 Most support for male condoms went to Nigeria (nearly 441 million pieces). Much smaller quantities of male condoms in Africa also went to Angola, Kenya and Uganda. In Asia, China received some male condoms and also received 5,000 pieces of female condoms from DFID. Zimbabwe was the major recipient of oral contraceptives at 5.6 million cycles. Kenya received nearly 4 million cycles of oral contraceptives. Zimbabwe received 20,600 implants. International Planned Parenthood Federation (IPPF) IPPF spent $2.36 million for the procurement of commodities in 2010. Out of this, IPPF sent commodities to different countries worth $1.9 million, and retained commodities worth $442,623 as ‘stock on hand’ for future distribution. Table 8: Regional distribution of IPPF resources Regions Total (US$) Percentage Africa 835,146 35.28 Arab States 114,444 4.83 Asia and Pacific 270,308 11.42 Latin America and Caribbean 704,794 29.77 Stock on hand 442,624 18.70 Total 2,367,316 100 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 10 The highest amount of commodities went to Africa (35.28 per cent). Latin American and Caribbean countries received the second highest quantities of commodities (29.77 per cent). Commodities retained as ‘stock on hand’ accounted for more than 18 per cent (Table 8). IPPF support went to 83 countries: 33 in Africa, 29 in Latin America and the Caribbean, 17 in Asia and Pacific and four in the Arab regions. Support ranged from approximately $191,000 for Honduras to a little over $500 for Kiribati, a Pacific Island country. Table 9: Support of IPPF, 2010 Quantity Value Percentage of total value Male condom 10,991,376 309,246 13.06 Female condom 39,000 26,286 1.11 Oral pills 15,290,555 808,764 34.16 Emergency contraceptives 21,040 18,726 0.79 Injectables 721,750 868,998 36.71 IUDs 104,140 41,346 1.75 Implants 4,855 146,129 6.17 Others 147,820 6.24 Total 2,367,315 100 IPPF’s highest support as shown in Table 9 was for injectables (36.71 per cent), followed by oral pills (34.16 per cent) and male condoms (13 per cent). Approximately 48 per cent of injectable support went to Latin American countries, followed by the African region. Support to other regions was minimal. In the Latin American region, Honduras received the highest quantity of injectables (135,200), followed by El Salvador (69,100). In Africa, Côte d’Ivoire received 54,700 injectables, followed by Democratic Republic of Congo with 36,700. In Asia, the Philippines received 14,500. In 2010, IFFP provided more than 15 million cycles of oral contraceptives. Guinea-Conakry received nearly 4 million cycles, and Democratic Republic of Congo received 2.6 million cycles. In Latin America, El Salvador received 2.3 million cycles and the next highest recipient of pills was Aruba with 480,600 cycles. Sarawak, with 136,620 cycles, was the highest recipient of pills in Asian and Pacific countries. Approximately 37 per cent of support for male condoms went to Africa, where the highest recipient was Burkina Faso (1.1 million pieces), followed by Zambia (933,120 pieces), Togo (549,936 pieces), Mozambique (354,240 pieces) and Niger (329,472 pieces). Some 27 per cent of support for male condoms went to Latin America, where the highest recipient was Chile (1.2 million pieces), followed by El Salvador (610,560 pieces) and Peru (302,400 pieces). IPPF spent $128,845 for spermicides and 16 African countries received approximately 87 per cent of this support. Mali received the highest amount of spermicides. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 11 Federal German Ministry for Economic Cooperation and Development/Kreditanstalt für Wiederaufbau (BMZ/KfW) BMZ/KfW provided more than $29 million in support for family planning commodities in 2010. Table 10: Regional distribution of BMZ/KfW support Regions Total (US$) Percentage Africa 9,898,095 33.92 Arab States 449,236 1.54 Asia Pacific 17,627,900 60.41 Latin America 1,205,558 4.13 Total 29,180,788 100 The Asia Pacific region over 60 per cent of BMZ/KfW support in 2010 (Cambodia, Nepal and Pakistan), followed by Africa with nearly 34 per cent (Burundi, Cameroon, Central African Republic, Chad, Congo- Brazzaville, Guinea, Guinea-Bissau, Mali, Sierra Leone, Somaliland and Tanzania). Commodities in a relatively small percentage of total value were also received by Yemen (1.54 per cent) in the Arab States region, and by four countries in Latin America (4.13 per cent), namely El Salvador, Guatemala, Honduras and Nicaragua (Table 10). Among all the countries that received commodities from BMZ/KfW, Cambodia received the most support at more than $14.6 million, followed by Cameroon at $3.2 million and Mali at $3.1 million. Sierra Leone was the lowest, with $15,300. Table 11: Support of BMZ/KfW, 2010 Quantity Value (US$) Percentage of total value Male condoms 294,856,894 10,432,288 35.75 Oral pills 25,528,888 14,060,892 48.19 Emergency contraceptives 15,000 15,300 0.05 Injectables 7,059,096 4,508,584 15.45 IUDs 208,494 163,725 0.56 Total 29,180,788 100 Male condoms amounting to 294 million pieces constituted nearly 36 per cent of BMZ/KfW’s total commodity support. Of this support, nearly 63 per cent went to Africa and 22 per cent went to Asia (Table 11). In Africa, Cameroon received 88 million pieces of male condoms and Mali received nearly 35 million pieces. In Asia, Pakistan received nearly 65 million pieces. In Latin America, Guatemala received 18 million pieces. BMZ/KfW provided more than 25.5 million cycles of oral contraceptives, excluding emergency contraceptives (Table 10), and value of this commodity was 48 per cent of the total support. Sixty-four per cent of support for oral contraceptives went to the Asia Pacific region, where Cambodia was the only recipient (10 million cycles). Cambodia received the highest quantity of injectables (3.4 million vials), Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 12 followed by Mali (1.5 million vials) and Nepal (1.1 million vials). In addition to these countries, Pakistan received 929,000 vials and Yemen 130,000 vials. Marie Stopes International (MSI) MSI provided over $1.7 million in commodities support to ten African and six Asian countries in 2010. In regional distribution, out of the total, nearly 55.7 per cent went to Asia, followed by Africa with 37.6 per cent (Table 12). In the Arab States region, support went to Sudan and Yemen. Bolivia in the Latin America region received support from MSI. The commodities that MSI provided included male condoms, oral pills (both combined and emergency contraceptive pills), injectables, IUDs and sub-dermal implants (Table 13). The figures for oral contraceptives in Table 12 contain both combined and emergency oral contraceptives. At 42.31 per cent, the percentage of oral contraceptives was highest among all five types of contraceptives that MSI provided. After pills, MSI support for male condoms was 25.93 per cent and for implants 23.52 per cent. IUDs accounted for 4.84 per cent and injectables for 3.42 per cent. Table 13: Support of MSI, 2010 Quantity Value Percentage of total value Male condom 13,567,520 442,934 25.93 Oral contraceptives 6 4,028,002 722,797 42.31 Injectable contraceptives 77,500 58,355 3.42 Intrauterine device (IUD) 216,793 82,610 4.84 Sub-dermal implants 36,222 401,782 23.52 Total 1,708,477 100 MSI provided male condoms to six countries in 2010, of which three were from Asia, two from Africa and one from the Arab States. The countries that received male condoms included Malawi (5.3 million), Mongolia (2.1 million), Afghanistan (1.6 million), Kenya (1.5 million) and Nepal (1.2 million). 6 Oral contraceptives contain both combined pills and emergency contraceptive mbined pills. Table 12: Regional distribution of MSI, 2010 Regions Total (US$) Percentage Africa 642,404 37.60 Asia 934,543 54.70 Arab States 131,086 7.67 Latin America 444 0.03 Total 1,708,477 100 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 13 Sierra Leone received 12,000 sets of implants. Several other African countries also received implants, including Burkina Faso, Kenya, Nigeria, Senegal, Sudan and Uganda. In Asia, Pakistan received implants from MSI, and in Latin America, Bolivia received a minimal supply of 50 sets. The Philippines received highest quantity of IUDs followed by Yemen and Madagascar. Sierra Leone received the highest quantity of injectables from MSI in 2010. Population Services International (PSI) PSI provided approximately $27 million worth of commodities in 2010. Out of this total, 49.78 per cent of support went to seven Asian countries and 46.31 per cent went to 23 African countries. In Latin America, 3.78 per cent of resources went to nine countries. One country in the Arab Stated received PSI assistance. Table 14: Regional distribution of PSI, 2010 Regions Total (US$) Per cent Africa 12,460,514 46.31 Asia 13,399,271 49.79 Arab States 31,353 0.12 Latin America 1,018,183 3.78 Total 26,909,321 100 Three African countries received more than $1 million worth of commodities from PSI. Those countries were Tanzania at$3.55 million, Nigeria at $1.26 million and Côte d’Ivoire at $1.21 million. In Asia, India received more than $8 million, followed by Cambodia at $3.8 million. In Latin America, Paraguay received the most support in that region at $581,404. PSI procured male and female condoms, oral contraceptives including emergency contraceptives, injectables, IUDs and sub-dermal implants. Male condoms were the dominant commodity (48.81 per cent), followed by oral contraceptives (28.82 per cent). The share of the other four commodities varied from 7 per cent to as low as 1.76 per cent (Table 15). Table 15: Support of PSI, 2010 Quantity Value (US$) Percentage of total value Male condom 446,906,368 13,134,268 48.81 Female condom 2,898,315 1,941,166 7.21 Oral contraceptives 30,639,977 7,754,569 28.82 Emergency contraceptive 1,450,000 699,704 2.60 Injectable Contraceptives 1,773,699 1,121,286 4.17 Intrauterine device (IUD) 980,870 473,804 1.76 Sub-dermal implants 81,000 1,784,524 6.63 Total 26,909,321 100 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 14 Regarding male condoms, five African countries received more than 10 million pieces from PSi. Those countries included Tanzania (111.6 million), Côte d’Ivoire (28.8 million), South Africa (28.4 million), Uganda (14.6 million) and Togo (12.3 million). In Asia, three countries received male condoms and all of them received more than 10 million pieces. Support to India was the highest with nearly 142 million pieces, while Lao People’s Democratic Republic received 17 million and Myanmar received 11.5 million. In Latin America, Guatemala received 3.1 million pieces. In support for female condoms, PSI provided approximately 2.9 million pieces, of which 92 per cent of went to Africa and 8 per cent to Asia. Countries from Arab States and Latin America did not receive female condoms from PSI. In Africa, Cameroon was the highest recipient of female condoms at more than 0.6 million pieces, followed by Nigeria, Mozambique and Tanzania (see Table on female condoms in appendix). PSI provided both combined and emergency contraceptive pills. Oral combined contraceptive pills accounted for 28.82 per cent of total PSI support for commodities. Of this amount, four Asian countries received over 87 per cent, including India (14.2 million cycles), Cambodia (11.4 million cycles), Pakistan (813,340 cycles) and Myanmar (720,000 cycles). In Africa, Nigeria received nearly 1.2 million cycles of oral combined pills. In Latin America, Paraguay received 1.8 million cycles and Guatemala 40,000 cycles. Only Nigeria, Myanmar and Paraguay received emergency contraceptive pills. Of support for injectables from PSI, 87 per cent went to Asia, where Cambodia received 1.1 million vials and Pakistan received 400,000 vials. African countries received 13 per cent of support, with Côte d’Ivoire at 227,000 vials.A majority IUDs (85 per cent) went to Asia, where Pakistan and India were the highest recipients, with 591,000 and 155,000 respectively. In Africa, a notable receiver was Uganda with 100,000 IUDs, followed by Tanzania and Democratic Republic of Congo. Three countries in Latin America received IUDs from PSI, including Nicaragua (30,000), El Salvador (25,000) and Guatemala (20,000). Nine countries in the Africa region received 100 per cent of 43,000 implants. United Nations Population Fund (UNFPA) In 2010, UNFPA’s total support for commodities was $82,391,543 7 (see Table 16). UNFPA provided support to 106 countries in 2010. Of this support, about 66 per cent went to the Africa region, followed by 13 per cent to Asia and the Pacific Islands; 12.88 per cent to Latin America and the Caribbean; and 7.22 per cent to Eastern Europe, Central Asia and the Arab States. UNFPA support went to 43 countries in Africa; 23 countries in Asia and the Pacific Islands; 19 countries in Eastern Europe, Central Asia and the Arab States; and 21 countries in Latin America and the Caribbean. 7 UNFPA data includes third party procurement Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 15 Table 16: Regional distribution of UNFPA support, 2010 Regions Total (US$) Per cent Africa 54,434,802 66.07 Asia 10,796,404 13.10 Arab States 5,951,283 7.22 Latin America 10,614,616 12.88 Others 8 594,439 0.72 Total 82,391,543 100.00 Of total expenditures, the share for sub-dermal implants was the highest (25.83 per cent). The share for injectables was close to implants (24.98 per cent), followed by male condoms (22.25 per cent), oral contraceptives (nearly 16 per cent) and finally female condoms (7.06 per cent) (Table 17). Table 17: Support of UNFPA, 2010 Quantity Value (US$) Percentage of total value Male condom 840,921,044 18,331,177 22.25 Female condom 9,852,149 5,813,821 7.06 Oral contraceptives 38,348,592 13,090,277 15.89 Emergency contraceptives 1,641,577 417,750 0.51 Injectables 52,699,184 20,580,674 24.98 IUDs 4,640,028 1,749,874 2.12 Implants 1,025,968 21,278,808 25.83 Others 9 1,129,162 1.37 Total 82,391,542 100 Ninety per cent of implants went to Africa. Twelve African countries received more than 20,000 implants each. Ethiopia was the largest implants recipient at 260,000 pieces, followed by Uganda at 114,200 pieces, Kenya at 75,000 and Burundi at 60,000. In other regions, Asia received 29,100 pieces, the Arab States received 21,451 and Latin America received 31,608. 8 Some commodities were given to IPPF and MSI. That amount has not been included in regional distribution. 9 The cost associated with the procurement of lubricants, sampling and testing of condoms was included as ‘others’. Value of lubricant was little, so it was put under ‘others’. To ensure quality of condoms, UNFPA conducts testing. The cost of testing includes testing cost and other associated expenditures. So, cost of testing was also included as ‘others’. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 16 Similar to implants, Africa was the major recipient of injectables (65.18 per cent), followed by Latin America (18.42 per cent), Asia (11.06 per cent) and the Arab States (5.34 per cent). Ten countries in Africa received more than 1 million vials of injectables. The highest quantity went to Malawi (5.3 million), followed by Nigeria (5.1 million) and Madagascar (5 million). The highest quantity in the Asia region went to Pakistan (over 2 million) followed by Myanmar (1.55 million) and Papua New Guinea (1.1 million). In the Arab States region, Uzbekistan received 1.5 million. In Latin America, five countries (Bolivia, El Salvador, Guatemala, Honduras and Nicaragua) received more than 1 million vials of injectables each. UNFPA supplied more than 39 million cycles of pills in 2010. Many countries received more than one million cycles:  Africa: Nigeria (3.4 million), Madagascar (3.1 million), Uganda (3 million) and Mozambique (1.6 million);  Asia: Myanmar (1.1 million) and Philippines (1 million);  Arab States: Yemen (3 million), Uzbekistan (1.1 million) and Tajikistan (1.1 million); and  Latin America: Ecuador (2.7 million), Uruguay (2.1 million) and Paraguay (1 million). UNFPA provided support for 4.64 million IUDs in 2010. Nearly 3 million IUDs went to Latin America followed by 2 million to the Arab State region, 1.87 million to Asia, and 466,906 to Africa. Two countries received more than 1 million IUDs: Pakistan and Uzbekistan. In 2010, UNFPA provided support for nearly 841 million pieces of male condoms and 9.8 million pieces of female condoms (Table 18). The value of male and female condoms constituted more than 29 per cent of the total UNFPA contribution in 2010, of which male condoms accounted for 22.25 per cent and female condoms for 7 per cent. Out of the total male condoms, more than 509 million pieces went to Africa, 187 million to Asia, 31 million to the Arab States and 100 million to Latin America (Table 18).  In Africa, Kenya received more than 180 million pieces. More than 10 million pieces went to Angola, Democratic Republic of Congo, Côte d’Ivoire, Malawi, Mozambique, Nigeria and Uganda.  In Asia, Pakistan received the highest quantity of male condom (132 million), followed by Myanmar (33 million) and Bhutan (3 million). East Timor and Lao PDR received 1 million pieces each.  In the Arab States region, the highest quantity of male condom went to Sudan (12 million) followed by Uzbekistan (3.6 million), Yemen (3.5 million), Belarus (3 million), Syria (2.8 million) and Tajikistan (2.1 million).  In Latin America, Cuba, Honduras, Mexico and Uruguay each received more than 10 millions pieces. Of the total, a little over 12 million pieces of male condoms were distributed through IPPF programmes in the developing countries. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 17 Table 18: Regional distribution of male and female condoms by UNFPA, 2010 Male condom Female condom Quantity % Quantity % Africa 509,311,940 60.57 8,230,149 83.54 Asia & Pacific 187,760,880 22.33 1,317,000 13.37 Arab States 31,195,584 3.71 143,000 1.45 Latin America 100,602,720 11.96 135,000 1.37 Others* 12,049,920 1.43 27,000 0.27 Total 840,921,044 100 9,852,149 100 * These quantities were given to organizations, and so were not included in the regional distribution. More than 83 per cent of female condoms went to Africa and 13 per cent went to Asia. Less than 2 per cent went to the Arab States and Latin America. The six major recipient African countries for female condoms were Mozambique (1.5 million), Zimbabwe (955,000), Malawi (800,000), Uganda (800,000), Kenya (715,000) and Niger (408,000). In Asia, Indonesia received 1 million pieces, Fiji received 200,000 and Myanmar received 83,000. In the Arab States region, Sudan received 1 million. UNFPA provided IPPF with 27,000 female condoms for other developing countries. United States Agency for International Development (USAID) USAID provided more than $76 million for commodities to 42 countries in 2010. Of this total support, 69.5 per cent of resources went to Africa followed by Asia at 21.43 per cent (Table 19). The Arab States region received a little over 5 per cent and Latin America and the Caribbean received 4 per cent. USAID support went to 23 countries in Africa, 10 countries in Asia, one country in the Arab States, and eight countries in Latin America and the Caribbean. The highest level of support in Africa went to Uganda ($8.8 million) and the lowest went to Burundi ($32,000). In Asia, the most support went to Pakistan ($8.6 million) and the lowest to China ($26,000). In the Arab States, the only recipient was Ukraine ( $3.8 million). In Latin America and the Caribbean, Haiti received $2 million and Guatemala received nearly $11,000. Along with other modern methods, USAID supported the Standard Days Method with $837,856 and lubricant with $187,667 (Table 20). The highest level of support from USAID went to injectables (34.91 per cent), followed by male condoms (30.46 per cent), oral pills (16.13 per cent) and implants (11.68 per cent). Table 19: Regional distribution of USAID, 2010 Regions Total (US$) Per cent Africa 52,826,916 69.50 Asia 16,292,513 21.43 Arab States 3,817,639 5.02 Latin America 3,077,671 4.05 Total 76,014,739 100 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 18 Table 20: Support of USAID, 2010 Methods Quantity Value (US$) Percentage of total value Male Condom 740,916,000 23,157,452 30.46 Female Condom 5,611,000 3,560,009 4.68 Oral contraceptive Pills 38,601,120 12,263,947 16.13 Injectable Contraceptives 23,844,400 26,540,350 34.91 Intrauterine device (IUD) 968,100 591,748 0.78 Sub-dermal implants 392,900 8,876,710 11.68 Standard Days Method 487,500 837,856 1.10 Others (lubricant) 3,535,000 186,667 0.25 Total 76,014,739 100 Male and female condoms together constituted more than 35 per cent of USAID’s total support in 2010. USAID provided support for more than 740 million male condoms and more than 3.5 million female condoms in 2010 (Table 20). Table 21 shows that nearly 50 per cent of support for male condoms went to Africa, followed by Asia with 34.6 per cent. Support to the Arab States was 8.45 per cent and Latin America regions received 7.5 per cent. Table 21: Regional distribution of male and female condoms, USAID 2010 Male condom Female condom Quantity % Quantity % Africa 366,066,000 49.41 4,816,000 85.83 Asia 256,542,000 34.62 305,000 5.44 Arab States 62,601,000 8.45 450,000 8.02 Latin America 55,707,000 7.52 40,000 0.71 Total 740,916,000 100 5,611,000 100.00 In terms of quantity for male condoms, Africa received support for 366 million pieces, followed by Asia (256 million pieces), Arab States (62 million pieces) and Latin American (55 million pieces) (See Annex 3). In Africa, six countries each received 25 million pieces or more. Those countries were Ethiopia (47 million), Uganda (47 million), Zimbabwe (44 million), Democratic Republic of Congo (33 million), Zambia (31 million) and Malawi (25 million). In Asia, the highest recipients of male condoms were Pakistan (170 million), Nepal (27 million), Bangladesh (20 million), Myanmar (15 million) and Afghanistan (10 million). Ukraine received support for 62.6 million male condoms in 2010 from USAID.In Latin America, Haiti was the highest recipient (24 million), followed by Peru (20 million) and Dominican Republic (11.3 million). Most of the female condoms went to Africa (85 per cent), followed by relatively much lesser quantities to the Arab States (8 per cent) and Asia (5.4 per cent). Less than 1 per cent of female condoms went to Latin American and Caribbean countries. Among the African countries, the highest quantity of female Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 19 condoms went to the Democratic Republic of Congo (more than 1.8 million pieces), followed by Malawi (1.5 million pieces) and Zambia (1.2 million pieces). Among the higher recipients in Asia, Myanmar received 200,000 pieces and Thailand received 100,000. Ukraine received 450,000 and in the Latin American region, Trinidad and Tobago received 40,000. Six countries from Africa received more than 1 million cycles of pills: Tanzania (4.5 million cycles), Mozambique (3.8 million cycles), Uganda (2.3 million), Rwanda (1.6 million), Madagascar (1.2 million) and Ethiopia (1.1 million). In Asia, Pakistan received the highest amount (8.1 million cycles), followed by Bangladesh (7.7 million). Ukraine from Europe received 1.7 million cycles. More than 84 per cent of the total 23.8 million vials of injectables went to Africa, where 17 countries received Injectables: Uganda (4.8 million vials), Ethiopia (2.8 million), Kenya (2.7 million), Ghana (2.2 million), Nigeria (2.1 million), Mozambique (1 million) and Rwanda (1 million). Most of the remaining support, 12 per cent, went to Asia where four countries received injectables: Pakistan (1.3 million), Bangladesh (768,000), Afghanistan (480,000) and Nepal (327,600). In Latin America, only Haiti received injectables (685,600) (Ssee Annex 3). Less than one million IUD pieces were provided by USAID. The highest quantity of IUDs went to Pakistan (366,600), followed by Bangladesh (94,200). Nigeria was the only country that received 100,000 pieces in Africa, although seven additional countries from Africa received support for IUDs. Ukraine received 288,000; Peru received 12,000 IUDs. Support for implants was nearly 12 per cent of the total value of USAID support, which provided 40,000 sets. Most of this support (94 per cent) went to Africa (see Annex 3). Fourteen African countries received support for implants. Ethiopia was the highest recipient, receiving 60,000 sets, followed by Zambia (52,000) and Tanzania (50,000). In Asia, Nepal receive 8,500 sets of Implants. Two Latin American countries, Haiti (14,200 sets) and Guatemala (500 sets), also received implants. Seven countries from Africa received the Standard Days Method. No other country from any other regions received this method. In Africa, the highest support for this method went to the Democratic Republic of Congo (400,000 sets) followed by Madagascar (30,000 sets). Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 20 C. DONOR SUPPORT FOR MALE AND FEMALE CONDOMS Male and female condoms are the only methods that provide couples simultaneous protection against unintended pregnancies and STIs/HIV. Male and female condoms, when used consistently and correctly, are highly effective at preventing STIs, including HIV. Indeed, male and female condoms are central to efforts to halt the spread of HIV as recognized at the ICPD in 1994 as well as by the UNGASS Political Declaration on HIV/AIDS, adopted unanimously by United Nations Member States on 2 June 2006. In particular, the female condom is currently the only technology that gives women and adolescent girls greater control over protecting themselves from HIV, other STIs and unintended pregnancy. The product, however, has not yet achieved its full potential due to inadequate promotional activities, insufficient supply and comparatively higher cost than male condoms ($0.80 for a polyurethane female condom versus $0.03 for a male latex condom). The Female Health Company recently developed a new version of the female condom FC2, which is nearly identical to its predecessor but is made of synthetic nitrile and considerably less expensive to manufacture. After technical consultation with WHO in January 2006 to review the new female condoms dossier, experts concluded that FC2 was compatible with the FC1 and recommended that all donors consider procuring it for public sector programmes. Condom requirements The total need for family planning condoms in low- and middle-income countries in 2015 is estimated at almost 5 billion pieces, according to a Reproductive Health Supplies Coalition report where condom requirements are estimated separately (those used primarily for family planning and those used primarily for prevention of HIV and other sexually transmitted infections). The total (for both purposes) would be nearly 18 billion in 2015. Yet, as large countries such as Brazil, China, India and South Africa do not depend on donors for their condom supply, the requirement for donor support is much less: nearly 4.4 billion in 2015 of which 2.4 billion are for STI/HIV prevention and 2.0 billion are for family planning 10 . Patterns and trends in donor support for condoms versus other contraceptives Figures 9 and 10 show trends in the distribution of donor support for condoms relative to other types of contraceptives from 2005 to 2010. Overall, donor support for condoms remained between 37 per cent to 43 per cent of all commodities. 10 Reproductive Health Supplies Coalition, Contraceptive Projections and the Donor Gap: Meeting the Challenge 2009. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 21 Support for male condoms did not follow any pattern, with rises and falls almost every alternate year since 2005. There was a drop in 2006, a rise in 2007, a drop in 2008, and then again an increase during 2009 and 2010. For female condoms there was a gradual increase between 2005 to 2008, then a sharp rise in 2009 from 14 million in 2008 to 38 million in 2009, followed by a sharp fall in 2010 to 18.5 million. $0 $50 $100 $150 $200 $250 $300 2005 2006 2007 2008 2009 2010 M il li o n s Figure 8: Expenditure on condoms and other contraceptives, 2005–2010 Condoms Other contraceptives Total 39.1 37.6 43.4 37.4 42.6 39.0 60.9 62.4 56.6 62.6 57.4 61.0 2005 2006 2007 2008 2009 2010 Figure 9: Proportion of expenditure: Condoms and other contraceptives, 2005–2010 Condoms Other contraceptives $207m $207m $222m S213m $239m $256m Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 22 Figure 12 summarizes trends in donor expenditures for female condoms by region from 2007 to 2010. There was an increase from 2007 to 2008 of $2.5 million, and then there was a sharp rise in 2009, doubling support by all donors for female condoms from $14 million to $29 million. But there was a sharp decrease in 2010 when support dropped to $12.6 million. For female condoms, more than 90 per cent of supplies went to sub-Saharan Africa, and most of the remaining went to Asia. - 20 40 60 80 100 120 2005 2006 2007 2008 2009 2010 M il li o n s Figure 10: Expenditure trend of male and female condoms, 2005-2010 Male condom Female condom Total - 10 20 30 40 50 60 70 80 90 100 2005 2006 2007 2008 2009 2010 M il li o n s Figure 11: Donor expenditure of male condoms, 2005–2010 Africa Asia Arab States Latin America Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 23 Detailed quantities and values for both male and female condoms, by country and regions, are appended in Annex 3. $0 $5 $10 $15 $20 $25 $30 $35 2007 2008 2009 2010 M il li o n s Figure 12: Donor expenditure of female condoms, 2007–2010 Africa Asia Arab States Latin America Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 24 D. COMPARISON OF CONTRACEPTIVE NEEDS AND DONOR SUPPORT This section compares donor support with estimated costs of contraception and condoms for STI/HIV prevention (from Reproductive Health Supplies Coalition, Contraceptives Projections and the Donor Gap, 2009). The donor support requirements were estimated for a set of 88 donor-dependent countries by leveraging data sources such as the DHS surveys to estimate the current contraceptive prevalence rate, current unmet need for family planning and the current method mix of different family planning options. The projected number of users was computed using population projections, projected CPR rates for all women and projected method mixes. The population receiving service (the number of women projected to be using each type of family planning service) was multiplied by the cost of a couple year protections to estimate the family planning costs. A separate calculation was performed to estimate the number of condoms need for STI/HIV prevention and added to the commodity requirements. The donor funding share was estimated based on historical donor shares. It is important to note that this is not meant to indicate that the historical donor share is the ’correct share’, but rather was used as a basis for asking the question, “What would donor costs be in the future if the donor share remained the same and the current unmet need was reduced to 0 by 2015?” Figure 13 clearly displays that the donor share requirements would nearly need to double in order for the current unmet need to be met in 2015. Figure 13: Projected contraceptive need Source: Reproductive Health Supplies Coalition, Contraceptives Projections and the Donor Gap, 2009 Several factors need to be kept in mind when analyzing resource requirements in the context of available funding. Individuals’ unmet needs for family planning, use of standard costs and exclusion of programming costs increase the requirements shown above; other factors reduce them. The following provides a brief overview of some of the main factors that influence the estimated requirements. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 25 Future needs for contraceptive commodities are determined by three key factors: (a) growth in the numbers of women of reproductive age as a consequence of high fertility rates in the past, (b) increasing demand for family planning, and (c) changes in the family planning methods used, particularly the shift from traditional to modern methods as programmes mature. The estimation of donor support requirements in 88 countries by the RH Supplies Coalition in 2009 revealed that the number of women of childbearing age is expected to increase by 33 per cent in the next 15 years, from 525 million in 2005 to 696 million in 2020. If current unmet need is to be met by 2015, the total number of users of modern methods would increase from 144 million to 252 million, an increase of 75 per cent. Even under the more moderate medium variant scenario, the number of modern method users is projected to increase by 49 per cent during that same period, from 144 million to 214 million. In both scenarios, around 80 per cent of this increase would take place in Asia and sub-Saharan Africa. Unmet need The projections of family planning users assume that the current unmet need for family planning is reduced to zero by 2015. There is no assumption of latent demand. According to UNFPA estimates, approximately 215 million women worldwide would like to limit or space the number of children they have, but are not using contraceptives. 11 Standard costs The projections of commodity requirements were developed assuming unit costs paid by USAID and UNFPA in 2006. Unit costs were weighted according to the quantities procured by the two agencies. An upward adjustment of 15 per cent was applied to account for transportation and wastage costs. These prices are at the very low end of the cost spectrum, which means that the actual costs might be substantially higher. Varying degrees of donor dependency There are also factors that effectively change the presented donor requirements. The numbers shown in the graph were calculated based on historical donor share which may change in the future. Linking donor support to CPR Contraceptive prevalence in developing countries has grown dramatically in the past decades. Since the mid-1960s, the contraceptive prevalence rate has increased from approximately 10 per cent to almost 60 per cent. The United Nations Population Division projections show that the reproductive-age population in developing countries will increase some 23 per cent between 2000 and 2015. To meet current growth rates, donor funding for contraceptives will need to increase by 60 per cent, from about $230 million per year today to about $370 million by 2020, or by more than 80 per cent to more than $420 million by 2020 to eliminate unmet need. 12 11 As defined by Demographic Health Surveys, ‘unmet need’ is the measure of the discrepancy between the number of women in surveys who respond that they would like to limit or space childbirth but are not currently using contraception. 12 Reproductive Health Supplies Coalition, Contraceptive Projection s and the Donor Gap: Meeting the Challenge 2009. Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 26 ANNEX 1: DONOR SUPPORT 2010 AT A GLANCE Table 22: Donor Support 2010 Donors Amount in(US$) Percentage DFID 16,590,831 7.06 IPPF 2,367,315 1.01 BMZ/KfW 29,180,788 12.41 MSI 1,708,477 0.73 PSI 26,909,321 11.44 UNFPA 82,391,543 35.04 USAID 76,014,739 32.32 Total 235,163,014 100.00 Table 23: Male Condom Donors Quantity Value( in US$) DFID 449,091,810 10,283,152 IPPF 10,991,376 309,246 BMZ/KfW 294,856,894 10,432,288 MSI 13,567,520 442,934 PSI 446,906,368 13,134,268 UNFPA 840,921,044 18,331,176 USAID 740,916,000 23,157,452 Total 2,797,251,012 76,090,517 Table 24: Female Condom Donors Quantity Value( in US$) DFID 5,000 3,300 IPPF 39,000 26,286 PSI 2,898,315 1,941,166 UNFPA 9,852,149 5,813,821 USAID 5,611,000 3,560,009 Total 18,405,464 11,344,582 Table 25: Oral Contraceptives Donors Quantity Value( in US$) DFID 9,580,400 2,525,795 IPPF 15,290,555 808,764 BMZ/KfW 25,528,888 14,060,892 MSI 3,893,002 666,847 PSI 30,639,977 7,754,569 UNFPA 38,348,592 13,090,277 USAID 38,601,120 12,263,947 Total 161,882,534 51,171,091 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 27 Table 26: Emergency Contraceptive Pills Donors Quantity Value( in US$) IPPF 21,040 18,726 BMZ/KfW 15,000 15,300 MSI 135,000 55,950 PSI 1,450,000 699,704 UNFPA 1,641,577 417,750 Total 3,262,617 1,207,429 Table 27: Injectable Contraceptives Donors Quantity Value( in US$) DFID 3,508,000 3,282,265 IPPF 721,750 868,998 BMZ/KfW 7,059,096 4,508,584 MSI 77,500 58,355 PSI 1,773,699 1,121,286 UNFPA 52,699,184 20,580,674 USAID 23,844,400 26,540,350 Total 89,683,629 56,960,511 Table 28: Intra Uterine Device Donors Quantity Value( in US$) IPPF 104,140 41,346 BMZ/KfW 208,494 163,725 MSI 216,793 82,610 PSI 980,870 473,804 UNFPA 4,640,028 1,749,875 USAID 968,100 591,748 Total 7,118,425 3,103,107 Table 29: Sub-dermal Implants Donors Quantity Value( in US$) DFID 20,600 496,319 IPPF 4,855 146,129 MSI 36,222 401,782 PSI 81,000 1,784,524 UNFPA 1,025,968 21,278,808 USAID 392,900 8,876,710 Total 1,561,545 32,984,272 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 28 Table 30: Quantity & Value of Commodities in 2010 Method Quantity Value Percentage Male Condoms 2,797,251,012 76,090,517 32.36 Female Condoms 18,405,464 11,344,582 4.82 Oral Contraceptives 161,882,534 51,171,091 21.76 Emergency Contraceptive 3,262,617 1,207,429 0.51 Injectables 89,683,629 56,960,511 24.22 IUDs 7,118,425 3,103,107 1.32 Implants 1,561,545 32,984,272 14.03 Other* 2,301,505 0.98 Total 235,163,014 100 Table 31: Regional Distribution of Commodities (Quantities) Regions Amount Percentage Africa 147,507,295 62.73 Asia & Pacific 59,502,351 25.30 Arab States 10,495,041 4.46 Latin America & Caribbean 16,621,266 7.07 Others 1,037,062 0.44 Total 235,163,015 100 Table 32: Comparison of Expenditure in US$, 2009-2010 Donors 2009 2010 Comparison 2009-2010 Change Percentage DFID 13,005,195 16,590,831 3,585,636 27.57 BMZ/KfW 16,189,032 29,180,788 12,991,756 80.25 PSI 17,942,658 26,909,321 8,966,663 49.97 UNFPA 81,136,535 82,391,543 1,255,008 1.55 USAID 87,549,507 76,014,739 (11,534,768) -13.18 IPPF & MSI 22,977,954 4,075,792 (18,902,162) -82.26 Total 238,800,882 235,163,014 (3,637,868) -1.52 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 29 Table 33: Comparison of Commodity Quantity Method 2009 2010 Change Change in % Male Condoms 2,721,195,550 2,797,251,012 76,055,462.00 2.79 Female Condoms 37,842,502 18,405,464 (19,437,038.00) (51.36) Oral Contraceptives 146,031,399 161,882,534 15,851,135.40 10.85 Emergency Contraceptive 4,758,270 3,262,617 (1,495,653.00) (31.43) Injectables 79,235,645 89,683,629 10,447,984.00 13.19 IUDs 6,247,021 7,118,425 871,404.00 13.95 Implants 1,893,894 1,561,545 (332,349.00) (17.55) Table 34: Expenditure Trend by Donor in US$, 2005-2010 Donors 2005 2006 2007 2008 2009 2010 DFID 4,645,009 12,074,215 22,509,607 11,082,505 13,005,195 16,590,831 BMZ/KfW 13,141,863 23,628,162 24,581,698 15,458,390 16,189,032 29,180,788 PSI 28,815,939 30,619,669 24,899,764 14,139,388 17,942,658 26,909,321 UNFPA 82,569,544 74,367,557 63,891,923 89,323,477 81,136,535 82,391,543 USAID 68,774,981 62,761,027 80,862,868 68,852,015 87,549,507 76,014,739 IPPF & MSI 9,571,480 5,104,072 6,410,753 14,872,391 22,977,954 4,075,792 Total 207,518,815 208,554,702 223,156,613 213,728,167 238,800,882 235,163,014 Percent of increase (or decrease than previous year) 0.50 7.00 -4.23 11.73 -1.52 Table 35: Expenditure Trend by Region in US$, 2005-2010 Regions 2005 2006 2007 2008 2009 2010 Africa 98,001,400 88,988,154 133,893,291 133,109,503 173,103,825 147,507,295 Asia & Pacific 62,061,112 72,810,718 60,184,220 53,243,126 37,240,205 59,502,351 Arab States, ME, CA, EU 14,450,838 10,770,186 11,019,114 8,214,680 10,317,812 10,495,041 Latin America & Caribbean 20,595,648 21,859,899 16,090,787 18,877,820 17,871,861 16,621,266 Others 12,409,817 14,125,745 1,969,201 283,037 267,179 1,037,062 Total 207,518,815 208,554,702 223,156,613 213,728,167 238,800,882 235,163,015 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 30 Table 36: Method-wise Expenditure Trend in US$, 2005-2010 Method 2005 2006 2007 2008 2009 2010 Male Condoms 75,716,312 68,903,030 83,472,771 65,665,032 72,609,025 76,090,517 Female Condoms 5,307,622 8,997,611 12,807,286 14,265,265 29,198,748 11,344,582 Oral Contraceptives 55,942,227 58,231,403 52,284,410 52,844,113 45,784,413 52,378,520 Injectables 58,884,772 58,409,796 53,250,968 53,237,932 52,609,728 56,960,511 IUDs 4,337,192 3,992,670 2,540,851 1,704,399 3,165,913 3,103,107 Implants 5,537,104 7,213,713 16,220,743 23,289,713 33,371,936 32,984,272 Other* 1,514,436 1,681,488 1,397,382 2,496,505 2,100,000 2,301,505 Total 207,239,665 207,429,712 221,974,412 213,502,958 238,839,763 235,163,014 Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 31 ANNEX 2: COMMODITIES: DONORS’ CONTRIBUTION 7.06 1.01 12.41 0.73 11.44 35.04 32.32 Figure 14: Commodity Expenditure (%) 2010 DFID IPPF BMZ/KfW MSI PSI UNFPA USAID Total: $ 235.16m 16.05 0.39 10.54 0.49 15.98 30.06 26.49 Figure 15: Quantity of Male Condom Supplied by Donors (%) 2010 DFID IPPF BMZ/KfW MSI PSI UNFPA USAID Total: 2,797m 0.03 0.21 15.75 53.53 30.49 Figure 16: Quantity of Female Condom Supplied by Donors (%) 2010 DFID IPPF PSI UNFPA USAID Total: 18.4m Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 32 5.92 9.45 15.77 2.40 18.93 23.69 23.85 Figure 17: Quantity of Oral Pills (Low dose & Progesteron only) Supplied by Donors (%) 2010 DFID IPPF BMZ/KfW MSI PSI UNFPA USAID Total: 161.88m 0.64 0.46 4.14 44.44 50.31 Figure 18: Quantity of Emergency Contraceptives Supplied by Donors (%) 2010 IPPF BMZ/KfW MSI PSI UNFPA Total : 3.26m 3.91 0.80 7.87 0.09 1.98 58.76 26.59 Figure 19: Quantity of Injectables Supplied by Donors (%) 2010 DFID IPPF BMZ/ KfW MSI Total: 89.68m Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 33 1.67 3.35 3.49 1.30 74.62 15.57 Figure 20: Quantity of IUD Supplied by Donors (%) 2010 IPPF BMZ/KfW MSI PSI UNFPA USAID Total: 7.11m 0.84 0.20 1.47 39.85 41.68 15.96 Figure 21: Quantity of Implant Supplied by Donors (%) 2010 DFID IPPF MSI PSI UNFPA USAID Total: 1.56m Donor Support for Contraceptives and Condoms for Family Planning and STI/HIV Prevention 2010 34 ANNEX 3: COUNTRY TABLES: DONORS, COMMODITIES AND VALUES Country Table 1: Male Condoms – Donors, Commodities and Values Country Table 2: Female Condoms – Donors, Commodities and Values Country Table 3: Oral Contraceptives – Donors, Commodities and Values Country Table 3: Oral Contraceptives – Donors, Commodities and Values Country Table 4: Emergency Contraceptive Pills – Donors, Commodities and Values Country Table 5: Injectables – Donors, Commodities and Values Country Table 6: IUD – Donors, Commodities and Values Country Table 7: Implant – Donors, Commodities and Values C o u n try T a b le 1 : M a le C o n d o m s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ A n g o la 4 ,1 7 6 ,2 1 6 1 2 5 ,2 8 6 2 0 ,0 0 0 ,4 4 8 4 2 6 ,4 0 0 3 ,0 0 0 ,0 0 0 1 0 9 ,0 2 6 2 7 ,1 7 6 ,6 6 4 6 6 0 ,7 1 2 B e n in 1 6 4 ,1 6 0 4 ,1 8 4 4 ,1 0 1 ,4 0 8 1 0 5 ,3 8 3 - - 3 ,4 0 2 ,0 0 0 1 0 6 ,4 5 6 7 ,6 6 7 ,5 6 8 2 1 6 ,0 2 3 B o tsw a n a 5 ,3 8 4 ,9 8 8 1 5 2 ,9 1 0 2 1 ,6 0 0 5 3 7 5 ,4 0 6 ,5 8 8 1 5 3 ,4 4 7 B u rk in a F a so 1 ,1 5 4 ,8 8 0 2 9 ,4 3 3 1 4 ,4 0 0 ,0 0 0 4 3 2 ,0 0 0 7 ,2 9 4 ,0 3 2 1 8 1 ,3 3 8 - - 2 2 ,8 4 8 ,9 1 2 6 4 2 ,7 7 1 B u ru n d i - - 2 ,8 8 0 ,0 0 0 8 6 ,4 0 0 3 ,0 0 2 ,4 0 0 6 3 ,2 0 2 - - 5 ,8 8 2 ,4 0 0 1 4 9 ,6 0 2 C a m e ro o n 7 6 ,0 3 2 1 ,9 3 8 8 8 ,2 0 0 ,0 0 0 3 ,3 6 8 ,3 6 8 - - 8 ,2 0 8 ,0 0 0 1 7 9 ,4 1 7 9 6 ,4 8 4 ,0 3 2 3 ,5 4 9 ,7 2 3 C e n tra l A frica n R e p u b lic 5 ,7 6 0 1 4 7 1 4 ,2 4 1 ,0 0 0 8 4 5 ,3 3 8 2 ,7 4 1 ,0 4 0 8 2 ,2 3 1 2 ,3 1 7 ,5 3 6 4 6 ,6 7 3 1 9 ,3 0 5 ,3 3 6 9 7 4 ,3 8 8 C h a d - - 7 ,0 0 0 ,0 0 0 3 6 5 ,5 0 4 3 ,7 0 5 ,9 8 4 9 1 ,5 7 5 1 0 ,7 0 5 ,9 8 4 4 5 7 ,0 7 9 C o n g o - - 1 ,8 7 2 ,0 0 0 5 0 ,8 3 0 1 ,8 7 2 ,0 0 0 5 0 ,8 3 0 C o n g o - B ra zza v ille 1 0 ,8 0 0 ,0 0 0 7 1 1 ,4 7 3 1 0 ,8 0 0 ,0 0 0 7 1 1 ,4 7 3 C o n g o , D e m o cra tic R e p u b lic o f 3 3 ,0 0 6 ,0 0 0 1 ,0 1 5 ,7 8 3 3 3 ,0 0 6 ,0 0 0 1 ,0 1 5 ,7 8 3 C o n g o , D R C 3 0 ,6 7 2 ,0 0 0 6 0 4 ,9 2 0 3 0 ,6 7 2 ,0 0 0 6 0 4 ,9 2 0 C o n g o , T h e D e m o cra tic R e p u b lic 2 0 1 ,6 0 0 5 ,1 3 8 2 0 1 ,6 0 0 5 ,1 3 8 C o te D 'Iv o ire - - 2 8 ,8 4 7 ,8 5 3 8 6 5 ,4 3 6 1 0 ,0 0 0 ,0 8 0 2 0 1 ,3 9 1 3 8 ,8 4 7 ,9 3 3 1 ,0 6 6 ,8 2 6 D e m o cra tic R e p u b lic o f C o n g o 6 ,6 1 6 ,4 0 0 1 9 8 ,4 9 2 6 ,6 1 6 ,4 0 0 1 9 8 ,4 9 2 E q u a to ria l G u in e a 1 ,0 0 0 ,8 0 0 2 4 ,8 8 1 1 ,0 0 0 ,8 0 0 2 4 ,8 8 1 E ritre a 4 ,5 9 3 ,6 0 0 1 0 0 ,8 7 4 4 ,5 9 3 ,6 0 0 1 0 0 ,8 7 4 E th io p ia - - 2 5 0 ,1 2 8 7 ,5 0 4 - - 4 7 ,7 5 7 ,0 0 0 1 ,5 8 6 ,0 0 5 4 8 ,0 0 7 ,1 2 8 1 ,5 9 3 ,5 0 9 G a b o n 3 7 ,4 4 0 2 ,8 2 7 3 7 ,4 4 0 2 ,8 2 7 G a m b ia 2 ,6 9 4 ,6 7 2 6 6 ,0 8 5 2 ,6 9 4 ,6 7 2 6 6 ,0 8 5 G h a n a - - - - 1 4 ,3 9 7 ,0 0 0 5 3 1 ,2 3 1 1 4 ,3 9 7 ,0 0 0 5 3 1 ,2 3 1 G u in e a 1 1 ,9 1 4 ,0 3 8 3 5 7 ,4 2 1 6 2 2 ,0 8 0 1 6 ,9 2 9 1 2 ,5 3 6 ,1 1 8 3 7 4 ,3 5 0 G u in e a -B issa u - - 2 ,3 6 1 ,3 8 4 6 0 ,6 8 3 2 ,8 8 0 ,0 0 0 6 5 ,0 5 0 5 ,2 4 1 ,3 8 4 1 2 5 ,7 3 3 K e n y a 3 3 ,5 0 2 1 ,0 0 5 - - 1 ,5 6 6 ,7 2 0 4 6 ,7 8 4 6 ,0 6 1 ,8 2 4 4 0 1 ,7 7 4 1 8 0 ,5 0 4 ,0 0 0 3 ,6 1 7 ,0 8 0 - - 1 8 8 ,1 6 6 ,0 4 6 4 ,0 6 6 ,6 4 3 Le so th o - - 2 ,0 0 1 ,6 0 0 6 0 ,0 4 8 - - 2 ,0 0 1 ,6 0 0 6 0 ,0 4 8 Lib e ria - - 6 8 2 ,8 5 4 2 0 ,4 8 6 - - 1 0 ,4 1 3 ,0 0 0 3 0 2 ,8 1 4 1 1 ,0 9 5 ,8 5 4 3 2 3 ,3 0 0 M a d a g a sca r - - - - - - - - 2 0 ,6 4 0 ,0 0 0 5 9 9 ,4 6 1 2 0 ,6 4 0 ,0 0 0 5 9 9 ,4 6 1 M a la w i 5 ,3 1 9 ,2 0 0 1 9 5 ,3 7 8 2 5 ,6 3 2 ,0 0 0 5 2 5 ,1 0 0 2 5 ,0 0 2 ,0 0 0 7 5 3 ,1 7 2 5 5 ,9 5 3 ,2 0 0 1 ,4 7 3 ,6 5 0 M a li - - 3 4 ,9 9 9 ,2 0 0 1 ,3 7 0 ,1 9 4 - - 4 ,2 6 8 ,5 9 2 8 6 ,7 0 6 1 ,8 4 2 ,0 0 0 8 2 ,1 9 1 4 1 ,1 0 9 ,7 9 2 1 ,5 3 9 ,0 9 1 M a u rita n ia - - 2 ,1 6 0 ,0 0 0 4 2 ,9 7 5 2 ,1 6 0 ,0 0 0 4 2 ,9 7 5 M o za m b iq u e 3 5 4 ,2 4 0 9 ,0 2 8 7 ,1 9 0 ,9 0 4 2 1 5 ,7 2 7 7 0 ,7 8 0 ,0 3 2 1 ,4 0 9 ,4 9 9 2 0 ,5 2 0 ,0 0 0 6 2 6 ,7 7 6 9 8 ,8 4 5 ,1 7 6 2 ,2 6 1 ,0 3 1 N a m ib ia 8 ,0 3 4 ,2 5 5 2 6 0 ,2 4 9 - - 8 ,0 3 4 ,2 5 5 2 6 0 ,2 4 9 N ig e r 3 2 9 ,4 7 2 1 1 ,0 9 4 - - 3 2 9 ,4 7 2 1 1 ,0 9 4 N ig e ria 4 4 0 ,9 3 5 ,5 4 4 1 0 ,0 6 2 ,4 0 4 1 4 4 ,0 0 0 3 ,6 7 0 - - 2 ,1 6 0 ,0 0 0 2 0 8 ,5 0 0 4 5 ,7 9 2 ,2 8 8 1 ,0 0 9 ,7 8 1 5 ,3 4 0 ,0 0 0 1 5 5 ,5 5 2 4 9 4 ,3 7 1 ,8 3 2 1 1 ,4 3 9 ,9 0 7 R w a n d a 1 1 ,5 2 0 2 9 4 6 ,0 0 0 ,0 4 8 2 8 1 ,2 5 2 4 ,7 6 6 ,4 0 0 1 0 0 ,9 5 5 1 2 ,3 0 0 ,0 0 0 3 7 6 ,4 7 3 2 3 ,0 7 7 ,9 6 8 7 5 8 ,9 7 4 S a o T o m e a n d P rin cip e 9 5 ,0 4 0 3 ,3 5 9 3 ,9 3 7 ,6 8 0 8 5 ,2 9 5 4 ,0 3 2 ,7 2 0 8 8 ,6 5 4 S e n e g a l - - 6 ,7 4 4 ,0 0 0 1 8 9 ,8 9 8 6 ,7 4 4 ,0 0 0 1 8 9 ,8 9 8 S ie rra Le o n e - - - - - - 7 ,2 0 0 ,0 0 0 1 4 5 ,0 0 0 - - 7 ,2 0 0 ,0 0 0 1 4 5 ,0 0 0 S o u th A frica 2 8 ,4 5 1 ,8 0 8 8 4 6 ,7 4 0 2 3 ,0 0 1 ,0 0 0 7 8 0 ,9 1 7 5 1 ,4 5 2 ,8 0 8 1 ,6 2 7 ,6 5 7 S w a zila n d 4 ,5 0 0 ,0 0 0 9 0 ,6 2 5 4 ,5 0 0 ,0 0 0 9 0 ,6 2 5 T a n za n ia - - - - 1 1 1 ,6 0 0 ,0 0 0 2 ,5 1 3 ,7 5 0 - - 1 5 ,5 4 6 ,0 0 0 4 8 9 ,5 1 2 1 2 7 ,1 4 6 ,0 0 0 3 ,0 0 3 ,2 6 2 T o g o 5 4 9 ,9 3 6 1 6 ,0 6 6 1 2 ,3 7 6 ,3 6 8 5 4 7 ,6 2 8 - - - - 1 2 ,9 2 6 ,3 0 4 5 6 3 ,6 9 4 U g a n d a 3 ,4 6 4 ,6 4 0 8 0 ,0 0 0 - - - - 1 4 ,6 0 0 ,6 8 8 3 5 9 ,3 5 5 5 9 ,8 7 0 ,4 4 8 1 ,1 9 4 ,6 1 6 4 7 ,5 7 4 ,0 0 0 1 ,4 9 4 ,2 4 7 1 2 5 ,5 0 9 ,7 7 6 3 ,1 2 8 ,2 1 8 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 3 4 A n n e x - 3 T o ta l Q u a n tity T o ta l A m o u n t in D e stin a tio n C o u n trie s: A frica U S A ID D F ID IP P F K F W M S I P S I U N F P A * C o u n try T a b le 1 : M a le C o n d o m s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Z a m b ia 9 3 3 ,1 2 0 2 3 ,7 8 2 4 2 0 ,0 0 0 1 2 ,6 0 0 1 ,0 1 5 ,2 6 8 2 9 ,2 1 3 3 1 ,0 0 5 ,0 0 0 9 9 7 ,2 7 3 3 3 ,3 7 3 ,3 8 8 1 ,0 6 2 ,8 6 8 Z im b a b w e - - - - 4 4 ,5 7 7 ,0 0 0 1 ,4 4 0 ,6 5 1 4 4 ,5 7 7 ,0 0 0 1 ,4 4 0 ,6 5 1 A frica T o ta l 4 4 8 ,6 0 9 ,9 0 2 1 0 ,2 6 8 ,6 9 5 4 ,0 5 7 ,2 0 0 1 1 0 ,9 5 8 1 8 4 ,4 3 4 ,2 3 8 7 ,5 3 6 ,6 9 9 6 ,8 8 5 ,9 2 0 2 4 2 ,1 6 2 2 4 9 ,8 8 3 ,5 5 0 7 ,2 0 0 ,7 4 9 5 0 9 ,3 1 1 ,9 4 0 1 0 ,4 5 6 ,9 4 6 3 6 6 ,0 6 6 ,0 0 0 1 1 ,6 3 7 ,4 3 8 1 ,7 6 9 ,2 4 8 ,7 5 0 4 7 ,4 5 3 ,6 4 7 A sia P a cific A fg h a n ista n 1 ,6 5 8 ,8 8 0 4 3 ,2 6 8 - - 1 0 ,0 5 0 ,0 0 0 2 6 2 ,9 6 9 1 1 ,7 0 8 ,8 8 0 3 0 6 ,2 3 7 B a n g la d e sh 1 8 7 ,2 0 0 4 ,3 5 6 2 0 ,3 9 1 ,0 0 0 5 8 3 ,3 7 3 2 0 ,5 7 8 ,2 0 0 5 8 7 ,7 2 9 B h u ta n 3 ,8 8 8 ,0 0 0 8 3 ,7 0 0 3 ,8 8 8 ,0 0 0 8 3 ,7 0 0 C a m b o d ia - - 7 ,7 7 6 ,0 0 0 2 3 3 ,2 8 0 - 7 ,7 7 6 ,0 0 0 2 3 3 ,2 8 0 C h in a 4 8 1 ,9 0 8 1 4 ,4 5 7 - - 3 9 9 ,0 0 0 1 1 ,5 5 5 8 8 0 ,9 0 8 2 6 ,0 1 2 C o o k Isla n d s 2 8 8 2 6 2 8 8 2 6 E a st T im o r 1 ,0 6 5 ,6 0 0 2 3 ,2 7 7 1 ,0 6 5 ,6 0 0 2 3 ,2 7 7 In d ia 1 4 1 ,7 9 5 ,9 9 8 4 ,2 5 3 ,8 8 0 1 4 1 ,7 9 5 ,9 9 8 4 ,2 5 3 ,8 8 0 In d o n e sia 1 3 0 ,3 2 0 3 ,2 0 8 1 3 0 ,3 2 0 3 ,2 0 8 Ira n (Isla m ic R e p u b lic O f) 4 9 9 ,9 6 8 1 2 ,5 6 9 4 9 9 ,9 6 8 1 2 ,5 6 9 K irib a ti 5 ,7 6 0 1 4 7 5 ,7 6 0 1 4 7 La o P e o p le 's D e m o cra tic R e p 1 ,0 0 0 ,0 8 0 2 5 ,6 9 7 1 ,0 0 0 ,0 8 0 2 5 ,6 9 7 La o s 1 7 ,0 0 0 ,2 6 0 6 0 2 ,9 1 9 1 ,6 7 4 ,0 0 0 6 1 ,4 3 2 1 8 ,6 7 4 ,2 6 0 6 6 4 ,3 5 1 M a la y sia - - 3 6 ,0 0 0 7 6 3 3 6 ,0 0 0 7 6 3 M a ld iv e s 7 2 ,0 0 0 1 ,7 7 3 7 2 ,0 0 0 1 ,7 7 3 M o n g o lia - - 2 ,1 6 0 ,0 0 0 8 4 ,7 0 0 6 ,7 8 8 ,3 0 4 1 6 8 ,4 1 4 8 ,9 4 8 ,3 0 4 2 5 3 ,1 1 4 M y a n m a r 4 3 ,2 0 0 1 ,1 0 1 - - 1 1 ,4 9 9 ,8 4 0 2 5 1 ,5 9 3 3 3 ,7 6 8 ,0 0 0 6 8 2 ,5 0 0 1 5 ,0 0 0 ,0 0 0 5 1 3 ,9 1 9 6 0 ,3 1 1 ,0 4 0 1 ,4 4 9 ,1 1 2 N e p a l 1 ,2 9 6 ,0 0 0 3 6 ,9 0 0 - - 2 ,2 4 6 ,4 0 0 5 4 ,7 3 5 2 7 ,1 8 0 ,0 0 0 7 7 4 ,9 4 0 3 0 ,7 2 2 ,4 0 0 8 6 6 ,5 7 5 P a k ista n 6 4 ,8 0 0 ,0 0 0 1 ,6 0 4 ,6 0 0 - - 1 3 2 ,1 8 4 ,8 0 0 3 ,0 6 1 ,3 6 3 1 7 0 ,4 5 4 ,0 0 0 4 ,6 3 4 ,6 5 7 3 6 7 ,4 3 8 ,8 0 0 9 ,3 0 0 ,6 2 0 P a p u a N e w G u in e a 4 ,5 9 5 ,4 0 4 1 3 7 ,8 6 2 4 ,5 9 5 ,4 0 4 1 3 7 ,8 6 2 P a p u a N e w G u in e a - - - - 6 0 0 ,0 0 0 2 9 ,6 7 4 6 0 0 ,0 0 0 2 9 ,6 7 4 P h ilip p in e s 3 6 5 ,7 6 0 9 ,3 2 2 - - 4 9 9 ,9 6 8 1 2 ,8 4 6 8 6 5 ,7 2 8 2 2 ,1 6 8 S a m o a 2 ,8 8 0 7 3 2 ,8 8 0 7 3 S o lo m o n Isla n d s 3 ,0 2 4 8 6 3 ,0 2 4 8 6 T h a ila n d 1 8 ,4 3 2 5 5 3 3 0 2 ,4 0 0 6 ,4 0 5 7 9 5 ,0 0 0 4 6 ,0 4 3 1 ,1 1 5 ,8 3 2 5 3 ,0 0 1 T o n g a E T C 4 3 ,2 0 0 2 ,9 7 4 4 3 ,2 0 0 2 ,9 7 4 V a n u ta 1 1 ,6 6 4 4 9 4 1 1 ,6 6 4 4 9 4 V ie t N a m - - 5 ,0 9 1 ,8 4 0 2 0 8 ,9 5 5 5 ,0 9 1 ,8 4 0 2 0 8 ,9 5 5 V ie tn a m 9 ,9 9 9 ,0 0 0 2 6 1 ,8 1 1 9 ,9 9 9 ,0 0 0 2 6 1 ,8 1 1 A sia P a cific T o ta l 4 8 1 ,9 0 8 1 4 ,4 5 7 4 7 5 ,7 7 6 1 4 ,2 2 3 6 4 ,8 0 0 ,0 0 0 1 ,6 0 4 ,6 0 0 5 ,1 1 4 ,8 8 0 1 6 4 ,8 6 8 1 8 2 ,6 8 5 ,9 3 4 5 ,4 8 0 ,0 8 7 1 8 7 ,7 6 0 ,8 8 0 4 ,3 5 0 ,5 6 0 2 5 6 ,5 4 2 ,0 0 0 7 ,1 8 0 ,3 7 3 6 9 7 ,8 6 1 ,3 7 8 1 8 ,8 0 9 ,1 6 7 A ra b S ta te s A lb a n ia 3 8 8 ,8 0 0 1 0 ,6 1 4 3 8 8 ,8 0 0 1 0 ,6 1 4 A R O 2 ,8 8 0 7 3 2 ,8 8 0 7 3 B e la ru s 3 ,0 6 3 ,7 4 4 6 9 ,2 8 6 3 ,0 6 3 ,7 4 4 6 9 ,2 8 6 B o sn ia a n d H e rze g o v in a 6 1 7 ,0 4 0 1 4 ,3 5 5 6 1 7 ,0 4 0 1 4 ,3 5 5 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 3 5 P S I U N F P A U S A ID T o ta l Q u a n tity T o ta l A m o u n t in D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I A n n e x - 3 C o u n try T a b le 1 : M a le C o n d o m s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ D jib o u ti 2 0 ,1 6 0 5 0 1 2 0 ,1 6 0 5 0 1 E g y p t 5 0 ,4 0 0 1 ,2 2 5 5 0 ,4 0 0 1 ,2 2 5 Ira q 2 8 8 ,0 0 0 7 ,3 4 0 7 3 4 ,4 0 0 2 0 ,0 4 8 1 ,0 2 2 ,4 0 0 2 7 ,3 8 8 K a za k h sta n 1 4 4 ,0 0 0 3 ,9 3 1 1 4 4 ,0 0 0 3 ,9 3 1 K o so v o 1 ,0 0 8 ,0 0 0 2 7 ,5 1 7 1 ,0 0 8 ,0 0 0 2 7 ,5 1 7 M o ro cco 1 0 0 ,9 4 4 6 ,5 1 4 1 0 0 ,9 4 4 6 ,5 1 4 O m a n 5 0 4 ,0 0 0 1 2 ,2 5 0 5 0 4 ,0 0 0 1 2 ,2 5 0 P a le stin e - - 3 0 2 ,4 0 0 8 ,2 5 5 3 0 2 ,4 0 0 8 ,2 5 5 S u d a n - - - - 6 9 9 ,9 8 4 3 1 ,3 5 3 1 2 ,0 9 6 ,0 0 0 2 8 7 ,6 0 5 1 2 ,7 9 5 ,9 8 4 3 1 8 ,9 5 8 S y ria n A ra b R e p u b lic 2 ,8 8 0 ,0 0 0 7 0 ,0 0 0 2 ,8 8 0 ,0 0 0 7 0 ,0 0 0 T a jik ista n 2 ,1 7 0 ,3 6 8 5 1 ,9 6 0 2 ,1 7 0 ,3 6 8 5 1 ,9 6 0 U k ra in e 6 2 ,6 0 1 ,0 0 0 2 ,6 5 9 ,7 3 1 6 2 ,6 0 1 ,0 0 0 2 ,6 5 9 ,7 3 1 U n ite d A ra b E m ira te s 5 ,0 4 0 1 0 7 5 ,0 4 0 1 0 7 U zb e k ista n 3 ,6 7 6 ,0 3 2 7 6 ,8 3 9 3 ,6 7 6 ,0 3 2 7 6 ,8 3 9 Y e m e n 2 ,7 0 6 ,6 2 4 8 5 ,4 3 1 1 ,5 6 6 ,7 2 0 3 5 ,9 0 4 3 ,5 3 5 ,2 0 0 8 6 ,9 0 1 7 ,8 0 8 ,5 4 4 2 0 8 ,2 3 6 A ra b S ta te s T o ta l - - 3 9 1 ,8 2 4 1 3 ,9 2 8 2 ,7 0 6 ,6 2 4 8 5 ,4 3 1 1 ,5 6 6 ,7 2 0 3 5 ,9 0 4 6 9 9 ,9 8 4 3 1 ,3 5 3 3 1 ,1 9 5 ,5 8 4 7 4 1 ,3 9 4 6 2 ,6 0 1 ,0 0 0 2 ,6 5 9 ,7 3 1 9 9 ,1 6 1 ,7 3 6 3 ,5 6 7 ,7 4 2 La tin A m e rica a n d C a rib b e a n A ru b a 6 7 ,5 3 6 1 ,8 0 5 6 7 ,5 3 6 1 ,8 0 5 B a rb a d o s 4 1 ,0 4 0 1 ,8 4 2 - - 4 1 ,0 4 0 1 ,8 4 2 B e lize 7 5 ,1 6 8 5 ,4 9 2 3 2 4 ,0 0 0 1 2 ,2 4 0 3 9 9 ,1 6 8 1 7 ,7 3 2 B o liv ia - - - - 1 ,1 4 2 ,9 2 8 2 7 ,7 8 0 1 ,1 4 2 ,9 2 8 2 7 ,7 8 0 C h ile 1 ,2 7 8 ,7 2 0 3 2 ,5 9 0 1 ,2 7 8 ,7 2 0 3 2 ,5 9 0 C o lo m b ia 1 ,1 0 8 ,2 2 4 2 7 ,5 8 2 1 ,1 0 8 ,2 2 4 2 7 ,5 8 2 C o sta R ica - - 2 4 0 ,8 0 0 9 ,2 8 5 - - 2 4 0 ,8 0 0 9 ,2 8 5 C u b a 2 1 ,5 0 0 ,2 0 8 7 9 7 ,5 7 8 2 1 ,5 0 0 ,2 0 8 7 9 7 ,5 7 8 C u ra ca o 2 8 ,8 0 0 7 3 4 2 8 ,8 0 0 7 3 4 D o m in ica n R e p u b lic 1 4 5 ,4 4 0 3 ,7 0 7 8 7 8 ,4 0 0 2 0 ,4 3 5 1 1 ,3 0 4 ,0 0 0 3 3 9 ,0 4 1 1 2 ,3 2 7 ,8 4 0 3 6 3 ,1 8 3 E cu a d o r 8 ,6 4 0 ,0 0 0 1 9 8 ,0 0 0 8 ,6 4 0 ,0 0 0 1 9 8 ,0 0 0 E l S a lv a d o r 6 1 0 ,5 6 0 1 5 ,5 6 1 4 ,3 2 0 ,0 0 0 1 1 8 ,5 0 0 7 5 6 ,0 0 0 2 6 ,7 2 8 6 ,4 5 0 ,0 4 8 1 5 3 ,3 0 0 1 2 ,1 3 6 ,6 0 8 3 1 4 ,0 8 8 G re n a d a 3 ,6 0 0 1 3 9 3 ,6 0 0 1 3 9 G u a te m a la - - 1 8 ,0 0 0 ,0 0 0 4 9 3 ,7 5 0 3 ,1 9 6 ,8 0 0 1 0 0 ,5 7 0 4 ,7 3 9 ,3 2 8 9 6 ,2 6 8 - - 2 5 ,9 3 6 ,1 2 8 6 9 0 ,5 8 7 H a iti 8 6 4 ,0 0 0 2 0 ,1 0 0 2 4 ,0 0 0 ,0 0 0 6 9 3 ,3 8 8 2 4 ,8 6 4 ,0 0 0 7 1 3 ,4 8 8 H o n d u ra s - - 9 ,8 6 8 ,0 3 2 2 9 9 ,0 3 3 2 ,2 5 3 ,6 0 0 7 1 ,7 1 1 1 1 ,0 0 0 ,0 1 6 2 5 2 ,0 8 4 - - 2 3 ,1 2 1 ,6 4 8 6 2 2 ,8 2 7 Ja m a ica 9 2 ,1 6 0 2 ,3 4 9 - - 9 2 ,1 6 0 2 ,3 4 9 M e x ico - - 2 5 ,7 0 0 7 7 1 2 0 ,9 4 9 ,8 4 0 4 2 1 ,8 9 0 2 0 ,9 7 5 ,5 4 0 4 2 2 ,6 6 1 N ica ra g u a - - 1 0 ,7 2 8 ,0 0 0 2 9 4 ,2 7 5 2 ,0 3 7 ,6 0 0 6 4 ,8 6 2 2 ,6 9 2 ,9 4 4 6 4 ,8 9 5 - - 1 5 ,4 5 8 ,5 4 4 4 2 4 ,0 3 2 P a n a m a - - 3 ,0 7 4 ,4 0 0 8 9 ,7 1 3 5 ,9 2 2 ,2 8 8 1 3 7 ,7 7 5 8 ,9 9 6 ,6 8 8 2 2 7 ,4 8 9 P a ra g u a y - - 1 ,7 2 8 ,0 0 0 4 6 ,2 0 0 4 ,6 2 6 ,4 3 2 1 0 7 ,6 2 9 - - 6 ,3 5 4 ,4 3 2 1 5 3 ,8 2 9 P e ru 3 0 2 ,4 0 0 7 ,7 0 7 - - 2 0 ,0 0 1 ,0 0 0 6 3 1 ,3 5 8 2 0 ,3 0 3 ,4 0 0 6 3 9 ,0 6 5 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 3 6 A n n e x - 3 D e stin a tio n C o u n trie s: A ra b D F ID IP P F K F W M S I P S I U N F P A U S A ID T o ta l Q u a n tity T o ta l A m o u n t in C o u n try T a b le 1 : M a le C o n d o m s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ S t V in ce n t 8 6 4 7 8 8 6 4 7 8 S u rin a m e 1 9 5 ,8 4 0 1 3 ,6 0 5 - - 1 9 5 ,8 4 0 1 3 ,6 0 5 T rin id a d a n d T o b a g o 1 8 ,1 4 4 1 ,4 5 5 4 0 2 ,0 0 0 1 6 ,1 2 3 4 2 0 ,1 4 4 1 7 ,5 7 8 U ru g u a y 1 0 ,0 8 0 ,0 0 0 2 1 7 ,0 0 0 1 0 ,0 8 0 ,0 0 0 2 1 7 ,0 0 0 V e n e zu e la 1 0 3 ,6 8 0 2 ,6 4 2 8 ,0 6 4 2 2 0 1 1 1 ,7 4 4 2 ,8 6 3 La tin A m e rica a n d C a rib b e a n T o ta l - - 2 ,9 6 3 ,9 5 2 8 9 ,7 0 6 4 2 ,9 1 6 ,0 3 2 1 ,2 0 5 ,5 5 8 - - 1 3 ,6 3 6 ,9 0 0 4 2 2 ,0 7 9 1 0 0 ,6 0 2 ,7 2 0 2 ,5 4 2 ,5 3 4 5 5 ,7 0 7 ,0 0 0 1 ,6 7 9 ,9 1 0 2 1 5 ,8 2 6 ,6 0 4 5 ,9 3 9 ,7 8 7 O T H E R S IP P F 1 2 ,0 4 9 ,9 2 0 2 3 9 ,7 4 3 1 2 ,0 4 9 ,9 2 0 2 3 9 ,7 4 3 IP P F S to ck o n H a n d 3 ,1 0 2 ,6 2 4 8 0 ,4 3 1 3 ,1 0 2 ,6 2 4 8 0 ,4 3 1 O T H E R S T o ta l - - 3 ,1 0 2 ,6 2 4 8 0 ,4 3 1 - - - - - - 1 2 ,0 4 9 ,9 2 0 2 3 9 ,7 4 3 - - 1 5 ,1 5 2 ,5 4 4 3 2 0 ,1 7 4 M a le C o n d o m T o ta l 4 4 9 ,0 9 1 ,8 1 0 1 0 ,2 8 3 ,1 5 2 1 0 ,9 9 1 ,3 7 6 3 0 9 ,2 4 6 2 9 4 ,8 5 6 ,8 9 4 1 0 ,4 3 2 ,2 8 8 1 3 ,5 6 7 ,5 2 0 4 4 2 ,9 3 4 4 4 6 ,9 0 6 ,3 6 8 1 3 ,1 3 4 ,2 6 8 8 4 0 ,9 2 1 ,0 4 4 1 8 ,3 3 1 ,1 7 6 7 4 0 ,9 1 6 ,0 0 0 2 3 ,1 5 7 ,4 5 2 2 ,7 9 7 ,2 5 1 ,0 1 2 7 6 ,0 9 0 ,5 1 7 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 3 7 O th e rs A n n e x - 3 D e stin a tio n C o u n trie s: La tin A m e rica a n d C a rib b e a n D F ID IP P F K F W M S I P S I U N F P A U S A ID T o ta l Q u a n tity T o ta l A m o u n t in U S $ C o u n try T a b le 2 : F e m a le C o n d o m s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ B o tsw a n a 1 ,9 0 0 1 ,2 5 4 - - - 1 ,9 0 0 1 ,2 5 4 B u rk in a F a so 2 ,0 0 0 1 ,3 4 8 - - - 2 ,0 0 0 1 ,3 4 8 B u ru n d i - - 2 0 0 ,0 0 0 1 1 7 ,0 0 0 - - 2 0 0 ,0 0 0 1 1 7 ,0 0 0 C a m e ro o n 2 ,0 0 0 1 ,3 4 8 6 0 0 ,0 0 0 3 9 6 ,0 0 0 1 0 0 ,0 0 0 6 0 ,0 0 0 7 0 2 ,0 0 0 4 5 7 ,3 4 8 C a p e V e rd e 9 ,0 0 0 5 ,4 0 0 9 ,0 0 0 5 ,4 0 0 C e n tra l A frica n R e p u b lic 1 ,0 0 0 6 7 4 - - 3 3 0 ,0 0 2 2 2 6 ,8 6 9 3 3 1 ,0 0 2 2 2 7 ,5 4 3 C h a d - - 1 7 0 ,0 0 1 1 2 4 ,8 3 6 1 7 0 ,0 0 1 1 2 4 ,8 3 6 C o n g o , D R e p u b lic 1 ,8 1 7 ,0 0 0 1 ,1 0 4 ,8 1 8 1 ,8 1 7 ,0 0 0 1 ,1 0 4 ,8 1 8 C o te D 'Iv o ire - - 5 1 ,9 1 4 3 4 ,2 6 3 3 0 0 ,0 0 0 1 8 0 ,0 0 0 3 5 1 ,9 1 4 2 1 4 ,2 6 3 E q u a to ria l G u in e a 1 0 ,0 0 0 6 ,0 0 0 1 0 ,0 0 0 6 ,0 0 0 G a m b ia 1 ,0 0 0 6 0 0 1 ,0 0 0 6 0 0 G h a n a - - 1 0 0 ,0 0 0 5 9 ,0 0 0 4 0 ,0 0 0 2 7 ,5 8 8 1 4 0 ,0 0 0 8 6 ,5 8 8 G u in e a 1 1 9 ,0 0 0 7 0 ,4 0 0 1 1 9 ,0 0 0 7 0 ,4 0 0 G u in e a -B issa u - - - - 5 ,0 0 0 3 ,0 0 0 5 ,0 0 0 3 ,0 0 0 K e n y a - - - - 7 1 5 ,0 0 0 4 1 5 ,0 0 0 - - 7 1 5 ,0 0 0 4 1 5 ,0 0 0 M a d a g a sca r - - - - - - 4 9 ,0 0 0 3 6 ,6 0 1 4 9 ,0 0 0 3 6 ,6 0 1 M a la w i 8 6 2 ,1 4 6 5 0 5 ,0 1 6 1 ,5 0 0 ,0 0 0 9 2 3 ,3 8 6 2 ,3 6 2 ,1 4 6 1 ,4 2 8 ,4 0 2 M a li - - - - 1 3 5 ,0 0 0 8 1 ,0 0 0 6 0 ,0 0 0 4 1 ,1 4 1 1 9 5 ,0 0 0 1 2 2 ,1 4 1 M a u rita n ia - - 1 5 ,0 0 0 9 ,0 0 0 1 5 ,0 0 0 9 ,0 0 0 M a u ritiu s - - 2 0 ,0 0 0 1 2 ,0 0 0 2 0 ,0 0 0 1 2 ,0 0 0 M o za m b iq u e - - 4 5 0 ,0 0 0 2 9 7 ,0 0 0 1 ,5 0 0 ,0 0 0 8 5 5 ,0 0 0 - - 1 ,9 5 0 ,0 0 0 1 ,1 5 2 ,0 0 0 N a m ib ia 1 3 4 ,7 6 5 8 8 ,9 4 5 2 0 0 ,0 0 0 1 1 7 ,0 0 0 3 3 4 ,7 6 5 2 0 5 ,9 4 5 N ig e r - - 5 2 5 ,0 0 0 3 0 4 ,5 0 0 5 2 5 ,0 0 0 3 0 4 ,5 0 0 N ig e ria - 1 ,0 0 0 6 7 4 6 5 9 ,8 5 2 4 3 5 ,5 0 2 4 0 8 ,0 0 0 2 4 1 ,8 0 0 - - 1 ,0 6 8 ,8 5 2 6 7 7 ,9 7 6 S a o T o m e a n d P rin cip e 1 ,0 0 0 6 7 4 - - 1 ,0 0 0 6 7 4 S ie rra Le o n e - - 4 0 3 ,0 0 0 2 4 1 ,8 0 0 - - 4 0 3 ,0 0 0 2 4 1 ,8 0 0 S o u th A frica - - 2 5 0 ,0 0 0 1 8 0 ,1 2 9 2 5 0 ,0 0 0 1 8 0 ,1 2 9 S w a zila n d 1 2 1 ,0 0 0 7 2 ,6 0 0 1 2 1 ,0 0 0 7 2 ,6 0 0 T a n za n ia - - 5 7 6 ,0 0 0 3 7 0 ,3 6 8 - - - - 5 7 6 ,0 0 0 3 7 0 ,3 6 8 T o g o - - 1 6 2 ,0 0 0 1 4 4 ,9 9 0 7 ,0 0 0 4 ,2 0 0 - - 1 6 9 ,0 0 0 1 4 9 ,1 9 0 U g a n d a - - - - - 8 0 0 ,0 0 0 4 6 8 ,0 0 0 - - 8 0 0 ,0 0 0 4 6 8 ,0 0 0 Z a m b ia 8 ,0 0 0 5 ,3 9 2 - - 2 2 0 ,0 0 0 1 4 1 ,6 0 0 1 ,1 0 0 ,0 0 0 6 6 7 ,2 7 6 1 ,3 2 8 ,0 0 0 8 1 4 ,2 6 8 Z im b a b w e 9 5 5 ,0 0 0 5 5 4 ,0 0 0 - - 9 5 5 ,0 0 0 5 5 4 ,0 0 0 A frica T o ta l - - 1 5 ,0 0 0 1 0 ,1 1 0 - - - - 2 ,6 3 6 ,4 3 1 1 ,7 6 8 ,3 2 2 8 ,2 3 0 ,1 4 9 4 ,8 7 5 ,6 2 1 4 ,8 1 6 ,0 0 0 2 ,9 8 0 ,9 3 9 1 5 ,6 9 7 ,5 8 0 9 ,6 3 4 ,9 9 2 B a n g la d e sh 1 ,0 0 0 6 0 0 - - 1 ,0 0 0 6 0 0 B h u ta n 5 ,0 0 0 3 ,0 0 0 5 ,0 0 0 3 ,0 0 0 C h in a 5 ,0 0 0 3 ,3 0 0 - - 5 ,0 0 0 3 ,5 5 2 1 0 ,0 0 0 6 ,8 5 2 E a st T im o r 1 ,0 0 0 6 0 0 1 ,0 0 0 6 0 0 F iji 2 0 0 ,0 0 0 1 1 6 ,0 0 0 2 0 0 ,0 0 0 1 1 6 ,0 0 0 In d ia 2 2 2 ,8 0 3 1 4 7 ,0 5 0 2 2 2 ,8 0 3 1 4 7 ,0 5 0 In d o n e sia 1 ,0 0 0 ,0 0 0 5 7 0 ,0 0 0 1 ,0 0 0 ,0 0 0 5 7 0 ,0 0 0 M o n g o lia - - 1 8 ,0 0 0 1 0 ,8 0 0 1 8 ,0 0 0 1 0 ,8 0 0 M y a n m a r - - - - 8 3 ,0 0 0 4 9 ,8 0 0 2 0 0 ,0 0 0 1 2 0 ,2 4 5 2 8 3 ,0 0 0 1 7 0 ,0 4 5 P a p a u N e w G u in e a 3 9 ,0 8 1 2 5 ,7 9 3 3 9 ,0 8 1 2 5 ,7 9 3 S o lo m o n Isla n d s 1 ,0 0 0 6 7 4 1 ,0 0 0 6 7 4 S ri La n k a 5 ,0 0 0 3 ,0 0 0 5 ,0 0 0 3 ,0 0 0 T h a ila n d - - - - 1 0 0 ,0 0 0 - 1 0 0 ,0 0 0 - V ie t N a m - - 4 ,0 0 0 2 ,4 0 0 4 ,0 0 0 2 ,4 0 0 A R O 1 ,0 0 0 6 7 4 1 ,0 0 0 6 7 4 A sia P a cific T o ta l 5 ,0 0 0 3 ,3 0 0 1 ,0 0 0 6 7 4 - - - - 2 6 1 ,8 8 4 1 7 2 ,8 4 3 1 ,3 1 7 ,0 0 0 7 5 6 ,2 0 0 3 0 5 ,0 0 0 1 2 3 ,7 9 7 1 ,8 9 0 ,8 8 4 1 ,0 5 7 ,4 8 8 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 3 8 U S A ID T o ta l Q u a n tity T o ta l A m o u n t in A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A * D e stin a tio n C o u n trie s: A sia P a cific C o u n try T a b le 2 : F e m a le C o n d o m s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ B o sn ia a n d H e rze g o v in a 4 ,0 0 0 2 ,4 0 0 4 ,0 0 0 2 ,4 0 0 D jib o u ti 3 ,0 0 0 1 ,8 0 0 3 ,0 0 0 1 ,8 0 0 K y rg y zsta n 2 0 ,0 0 0 1 2 ,0 0 0 2 0 ,0 0 0 1 2 ,0 0 0 M o ro cco 2 ,0 0 0 1 ,3 4 8 2 ,0 0 0 1 ,3 4 8 S u d a n - - - - 1 0 6 ,0 0 0 6 2 ,6 0 0 1 0 6 ,0 0 0 6 2 ,6 0 0 T u rk m e n ista n 1 0 ,0 0 0 6 ,0 0 0 1 0 ,0 0 0 6 ,0 0 0 U k ra in e 4 5 0 ,0 0 0 4 1 8 ,5 0 8 4 5 0 ,0 0 0 4 1 8 ,5 0 8 A ra b S ta te s T o ta l 5 ,0 0 0 3 ,3 0 0 4 ,0 0 0 2 ,6 9 6 - - - - 2 6 1 ,8 8 4 1 7 2 ,8 4 3 1 ,4 6 0 ,0 0 0 8 4 1 ,0 0 0 7 5 5 ,0 0 0 5 4 2 ,3 0 5 5 9 5 ,0 0 0 5 0 4 ,6 5 6 B o liv ia - - 6 ,0 0 0 3 ,6 0 0 6 ,0 0 0 3 ,6 0 0 C o lo m b ia 5 ,0 0 0 3 ,0 0 0 5 ,0 0 0 3 ,0 0 0 C o sta R ica 1 ,0 0 0 6 7 4 - - 9 ,0 0 0 5 ,4 0 0 1 0 ,0 0 0 6 ,0 7 4 E cu a d o r 2 0 ,0 0 0 1 2 ,0 0 0 2 0 ,0 0 0 1 2 ,0 0 0 E l S a lv a d o r - - - - 5 8 ,0 0 0 3 4 ,8 0 0 5 8 ,0 0 0 3 4 ,8 0 0 H a iti 1 0 ,0 0 0 6 ,0 0 0 - - 1 0 ,0 0 0 6 ,0 0 0 P e ru - - 2 0 ,0 0 0 1 2 ,0 0 0 - - 2 0 ,0 0 0 1 2 ,0 0 0 T rin id a d a n d T o b a g o - - 4 0 ,0 0 0 3 6 ,7 6 5 4 0 ,0 0 0 3 6 ,7 6 5 U ru g u a y 5 ,0 0 0 3 ,0 0 0 5 ,0 0 0 3 ,0 0 0 V e n e zu e la - - 2 ,0 0 0 1 ,2 0 0 2 ,0 0 0 1 ,2 0 0 La tin A m e rica a n d C a rib b e a n T o ta l - - 1 ,0 0 0 6 7 4 - - - - - - 1 3 5 ,0 0 0 8 1 ,0 0 0 4 0 ,0 0 0 3 6 ,7 6 5 1 7 6 ,0 0 0 1 1 8 ,4 3 9 O T H E R S D e n m a rk (o th e rs) 3 ,0 0 0 1 ,8 0 0 3 ,0 0 0 1 ,8 0 0 IP P F 2 4 ,0 0 0 1 4 ,4 0 0 2 4 ,0 0 0 1 4 ,4 0 0 IP P F S to ck o n H a n d 1 9 ,0 0 0 1 2 ,8 0 6 1 9 ,0 0 0 1 2 ,8 0 6 O T H E R S T o ta l - - 1 9 ,0 0 0 1 2 ,8 0 6 - - - - - - 2 7 ,0 0 0 1 6 ,2 0 0 - - 4 6 ,0 0 0 2 9 ,0 0 6 F e m a le C o n d o m T o ta l 1 0 ,0 0 0 6 ,6 0 0 4 0 ,0 0 0 2 6 ,9 6 0 - - - - 3 ,1 6 0 ,1 9 9 2 ,1 1 4 ,0 0 9 1 1 ,1 6 9 ,1 4 9 6 ,5 7 0 ,0 2 1 5 ,9 1 6 ,0 0 0 3 ,6 8 3 ,8 0 6 1 8 ,4 0 5 ,4 6 4 1 1 ,3 4 4 ,5 8 2 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 3 9 * U N F P A d a ta in clu d e s th ird p a rty p ro cu re m e n ts U S A ID T o ta l Q u a n tity T o ta l A m o u n t in U S $ IP P F K F W M S I P S I U N F P A La tin A m e rica a n d C a rib b e a n A n n e x - 3 D e stin a tio n C o u n trie s: A ra b S ta te s D F ID C o u n try T a b le 3 : O ra l C o n tra ce p tiv e s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ B e n in 7 2 0 ,0 0 0 2 ,3 0 4 - - 5 0 ,7 0 0 1 6 ,9 0 0 2 6 4 ,0 0 0 9 9 ,3 8 1 1 ,0 3 4 ,7 0 0 1 1 8 ,5 8 5 B u rk in a F a so 3 6 ,0 0 0 1 1 ,8 4 4 - - 9 7 2 ,6 6 4 3 0 6 ,2 8 5 - - 1 ,0 0 8 ,6 6 4 3 1 8 ,1 2 9 C a m e ro o n - - 5 0 ,0 0 0 1 2 ,5 0 0 5 1 2 ,0 0 0 1 6 2 ,1 7 5 5 6 2 ,0 0 0 1 7 4 ,6 7 5 C a p e V e rd e 1 7 0 ,0 0 0 5 6 ,5 8 6 1 7 0 ,0 0 0 5 6 ,5 8 6 C e n tra l A frica n R e p u b lic 8 4 7 ,2 5 2 1 4 ,5 5 6 - - 4 8 0 ,9 4 3 1 5 6 ,1 0 9 1 ,3 2 8 ,1 9 5 1 7 0 ,6 6 5 C h a d 2 ,1 6 0 7 1 1 - - 2 ,1 6 0 7 1 1 C o m o ro s 3 0 ,0 0 0 1 0 ,0 0 0 3 0 ,0 0 0 1 0 ,0 0 0 C o n g o 7 2 0 2 3 7 2 0 2 ,8 5 7 6 9 ,8 6 6 2 0 3 ,5 7 7 7 0 ,1 0 3 C o n g o , D e m o cra tic R e p u b lic o f 4 1 1 ,8 4 0 1 3 6 ,0 3 3 4 1 1 ,8 4 0 1 3 6 ,0 3 3 C o n g o , T h e D e m o cra tic R e p u b lic 2 ,6 0 4 ,5 0 0 1 6 ,2 0 9 3 9 ,9 9 9 1 8 ,2 6 6 2 ,6 4 4 ,4 9 9 3 4 ,4 7 5 C o te D 'Iv o ire 6 6 ,2 4 0 2 0 ,9 2 5 6 9 5 ,6 9 2 1 7 3 ,9 2 3 1 3 7 ,0 0 0 4 7 ,8 3 0 8 9 8 ,9 3 2 2 4 2 ,6 7 8 E q u a to ria l G u in e a 1 9 ,9 9 8 7 ,8 9 9 1 9 ,9 9 8 7 ,8 9 9 E ritre a 9 0 ,9 9 9 3 1 ,0 7 3 9 0 ,9 9 9 3 1 ,0 7 3 E th io p ia 1 1 7 ,1 2 0 3 9 ,3 1 8 - - - - 1 ,1 5 0 ,5 6 0 3 5 0 ,6 3 9 1 ,2 6 7 ,6 8 0 3 8 9 ,9 5 7 G a b o n 7 2 0 3 2 6 7 2 0 3 2 6 G a m b ia 4 3 0 ,2 0 0 1 6 1 ,9 6 5 4 3 0 ,2 0 0 1 6 1 ,9 6 5 G h a n a 4 0 ,3 2 0 1 3 ,2 6 5 - - - - 4 0 ,3 2 0 1 3 ,2 6 5 G u in e a 5 0 0 ,0 0 0 1 6 0 ,0 0 0 4 3 0 ,0 0 2 1 5 2 ,8 6 8 9 3 0 ,0 0 2 3 1 2 ,8 6 8 G u in e a -B issa u 9 ,1 0 0 3 ,6 7 6 - - 3 3 ,9 8 4 1 3 ,0 5 5 4 3 ,0 8 4 1 6 ,7 3 1 G u in e a -C o n a k ry 3 ,9 9 2 ,2 4 0 1 7 ,8 4 9 3 ,9 9 2 ,2 4 0 1 7 ,8 4 9 K e n y a 3 ,9 1 0 ,0 0 0 1 ,2 5 7 ,0 6 5 4 9 4 ,5 0 0 8 ,0 2 6 - - 5 7 0 ,0 0 0 1 8 0 ,3 2 0 5 0 6 ,8 8 0 1 6 7 ,4 7 9 5 ,4 8 1 ,3 8 0 1 ,6 1 2 ,8 9 0 Le so th o 1 8 ,0 0 0 5 ,8 3 6 - - 4 1 3 ,0 0 4 1 3 4 ,8 6 3 4 3 1 ,0 0 4 1 4 0 ,6 9 9 Lib e ria 1 4 ,5 2 0 5 ,0 6 7 - - - - 2 6 0 ,6 4 0 8 2 ,1 2 1 2 7 5 ,1 6 0 8 7 ,1 8 8 M a d a g a sca r 3 ,0 0 0 2 ,1 5 8 2 ,0 0 5 ,2 0 0 5 4 5 ,2 3 5 3 ,1 5 7 ,8 2 1 9 6 2 ,2 3 6 1 ,2 4 3 ,2 0 0 4 1 6 ,6 6 1 6 ,4 0 9 ,2 2 1 1 ,9 2 6 ,2 8 9 M a la w i 6 2 5 ,7 0 0 1 9 5 ,9 5 7 - - 6 2 5 ,7 0 0 1 9 5 ,9 5 7 M a li 5 0 ,8 8 0 1 6 ,3 9 1 2 ,6 0 0 ,0 0 0 3 4 6 ,0 6 0 - - 1 2 ,8 0 0 5 ,4 8 8 9 9 9 ,6 0 0 3 7 2 ,4 0 4 3 ,6 6 3 ,2 8 0 7 4 0 ,3 4 3 M a u rita n ia 2 4 5 ,0 4 0 2 ,4 2 6 5 7 1 ,9 7 9 2 1 5 ,9 2 9 8 1 7 ,0 1 9 2 1 8 ,3 5 5 M a u ritiu s 1 6 ,5 6 0 5 ,2 8 7 1 3 0 ,0 0 0 4 1 ,1 2 6 1 4 6 ,5 6 0 4 6 ,4 1 3 M o za m b iq u e 7 ,2 0 0 2 ,8 1 5 - - 1 ,6 4 4 ,4 3 5 6 9 6 ,5 7 3 3 ,8 4 1 ,9 2 0 1 ,1 8 8 ,7 9 0 5 ,4 9 3 ,5 5 5 1 ,8 8 8 ,1 7 8 N ig e r 5 4 0 ,8 8 0 8 ,5 3 4 4 1 2 ,4 4 6 1 7 8 ,9 3 1 9 5 3 ,3 2 6 1 8 7 ,4 6 5 N ig e ria 1 2 3 ,0 0 0 1 ,8 6 2 - - 3 ,4 2 4 ,0 0 0 1 ,0 5 7 ,3 7 0 - - 3 ,5 4 7 ,0 0 0 1 ,0 5 9 ,2 3 2 R w a n d a - - - - - - 1 ,6 7 2 ,5 6 0 5 6 7 ,7 0 6 1 ,6 7 2 ,5 6 0 5 6 7 ,7 0 6 S a o T o m e a n d P rin cip e 1 ,4 4 0 5 6 3 7 ,7 2 8 2 ,5 7 6 9 ,1 6 8 3 ,1 3 9 S e n e g a l - - - - 9 0 2 ,6 4 0 2 9 2 ,6 1 9 9 0 2 ,6 4 0 2 9 2 ,6 1 9 S e y ch e lle s M H O 1 ,6 0 8 1 ,5 5 2 1 ,6 0 8 1 ,5 5 2 S ie rra Le o n e 7 ,2 0 0 2 ,7 2 6 5 5 ,0 0 2 1 5 ,1 1 3 7 3 6 ,1 7 6 2 5 9 ,9 6 2 - - 7 9 8 ,3 7 8 2 7 7 ,8 0 2 S o m a lila n d 4 7 9 ,8 8 8 1 1 9 ,9 7 2 4 7 9 ,8 8 8 1 1 9 ,9 7 2 T a n za n ia 1 6 ,1 2 0 5 ,7 6 9 1 ,0 4 5 ,0 0 0 2 6 1 ,2 5 0 - - 1 5 5 ,9 0 0 5 3 ,5 2 8 4 ,9 2 4 ,0 8 0 1 ,5 6 0 ,8 5 8 6 ,1 4 1 ,1 0 0 1 ,8 8 1 ,4 0 5 T o g o 7 1 2 ,0 0 0 3 ,4 7 0 - - 1 6 ,2 6 0 5 ,4 2 0 1 8 0 ,0 0 0 6 7 ,0 4 2 9 0 8 ,2 6 0 7 5 ,9 3 2 U g a n d a 2 5 ,2 0 0 8 ,2 9 1 - - - - 2 ,1 1 0 ,0 0 0 6 4 5 ,1 9 1 2 ,3 0 1 ,8 4 0 8 0 6 ,2 7 3 4 ,4 3 7 ,0 4 0 1 ,4 5 9 ,7 5 5 Z a m b ia 4 0 ,3 2 0 1 3 ,8 0 1 - - - - - - 4 0 ,3 2 0 1 3 ,8 0 1 Z im b a b w e 5 ,6 7 0 ,4 0 0 1 ,2 6 8 ,7 3 0 5 ,6 7 0 ,4 0 0 1 ,2 6 8 ,7 3 0 A frica T o ta l 9 ,5 8 0 ,4 0 0 2 ,5 2 5 ,7 9 5 1 0 ,7 5 3 ,8 4 0 2 3 5 ,7 9 5 4 ,6 2 4 ,8 8 8 8 8 7 ,2 8 2 5 5 ,0 0 2 1 5 ,1 1 3 2 ,7 5 0 ,8 9 2 7 3 1 ,6 5 8 1 7 ,5 8 9 ,5 9 5 5 ,8 4 6 ,3 4 5 1 8 ,6 5 9 ,7 6 0 6 ,1 0 8 ,0 0 6 6 4 ,0 1 4 ,3 7 7 1 6 ,3 4 9 ,9 9 4 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 0 U S A ID T o ta l Q u a n tity T o ta l A m o u n t in A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A * C o u n try T a b le 3 : O ra l C o n tra ce p tiv e s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ A fg h a n ista n 2 0 0 ,0 0 0 4 7 ,0 0 3 8 0 ,0 0 0 2 6 ,6 6 6 6 6 0 ,2 4 0 1 9 8 ,5 8 1 9 4 0 ,2 4 0 2 7 2 ,2 5 0 B a n g la d e sh - - 7 ,7 7 6 ,0 0 0 2 ,4 1 7 ,1 4 7 7 ,7 7 6 ,0 0 0 2 ,4 1 7 ,1 4 7 B h u ta n 5 0 ,0 0 0 1 6 ,6 6 7 5 0 ,0 0 0 1 6 ,6 6 7 C a m b o d ia 2 0 ,0 0 0 ,0 0 0 1 2 ,9 6 1 ,7 6 0 1 0 ,4 9 9 ,9 6 5 2 ,6 2 4 ,9 9 1 1 ,0 0 8 ,0 0 0 2 5 2 ,6 6 7 - - 3 1 ,5 0 7 ,9 6 5 1 5 ,8 3 9 ,4 1 8 C o o k Isla n d s 7 ,9 2 0 2 ,8 4 5 7 ,9 2 0 2 ,8 4 5 E a st T im o r 4 3 ,5 0 0 1 6 ,9 5 6 4 3 ,5 0 0 1 6 ,9 5 6 F iji 5 4 ,8 7 3 2 2 ,4 6 8 5 4 ,8 7 3 2 2 ,4 6 8 In d ia 1 4 ,2 1 5 ,7 8 0 3 ,5 5 3 ,9 4 5 1 4 ,2 1 5 ,7 8 0 3 ,5 5 3 ,9 4 5 K o re a , D e m o cra tic P e o p le 's R e p 1 4 6 ,1 0 0 5 1 ,9 0 1 1 4 6 ,1 0 0 5 1 ,9 0 1 La o P e o p le 's D e m o cra tic R e p 2 5 0 ,0 0 0 1 0 8 ,4 5 8 2 5 0 ,0 0 0 1 0 8 ,4 5 8 M a la y sia 4 6 ,0 4 0 2 5 ,1 9 5 - - 4 6 ,0 4 0 2 5 ,1 9 5 M o n g o lia - - 3 4 ,0 0 0 1 1 ,2 9 1 1 7 0 ,0 0 0 5 6 ,6 6 6 2 0 4 ,0 0 0 6 7 ,9 5 7 M y a n m a r 1 2 ,9 6 0 4 ,2 6 4 2 ,7 0 0 ,0 0 0 4 5 3 ,9 0 0 7 2 0 ,0 0 0 1 5 8 ,4 0 0 1 ,1 2 0 ,0 0 0 3 5 5 ,9 2 5 - - 4 ,5 5 2 ,9 6 0 9 7 2 ,4 8 9 N e p a l 5 0 0 ,0 0 0 8 5 ,0 0 0 - - - - 7 3 4 ,4 0 0 2 4 5 ,9 6 9 1 ,2 3 4 ,4 0 0 3 3 0 ,9 6 9 P a k ista n - - - - 8 1 3 ,3 4 0 2 0 3 ,3 3 5 1 0 0 ,0 0 1 3 6 ,1 3 3 8 ,1 1 4 ,4 0 0 2 ,5 0 3 ,0 5 0 9 ,0 2 7 ,7 4 1 2 ,7 4 2 ,5 1 8 P a p u a N e w G u in e a 1 0 ,0 8 0 3 ,4 0 6 1 ,0 0 0 3 3 3 - - 1 1 ,0 8 0 3 ,7 3 9 P h ilip p in e s 8 8 ,4 4 4 3 9 ,9 0 9 - - 1 ,0 5 0 ,0 0 0 4 4 5 ,2 3 0 1 ,1 3 8 ,4 4 4 4 8 5 ,1 3 9 S a b a h 7 5 ,9 2 0 3 1 ,9 6 9 7 5 ,9 2 0 3 1 ,9 6 9 S a m o a 6 ,4 8 0 2 ,3 3 1 6 ,4 8 0 2 ,3 3 1 S a ra w a k 1 3 6 ,6 2 0 5 4 ,6 5 7 1 3 6 ,6 2 0 5 4 ,6 5 7 S o lo m o n Isla n d s 1 ,4 4 0 5 6 3 1 ,4 4 0 5 6 3 T o n g a E T C 7 2 0 2 3 7 7 2 0 2 3 7 T u v a lu 7 2 0 3 2 6 7 2 0 3 2 6 V a n u ta 1 ,3 2 0 4 4 1 1 ,3 2 0 4 4 1 V ie t N a m 2 9 ,5 2 0 9 ,7 1 2 - - 2 9 ,5 2 0 9 ,7 1 2 A sia P a cific T o ta l - - 4 1 8 ,1 8 4 1 7 5 ,8 5 6 2 0 ,0 0 0 ,0 0 0 1 2 ,9 6 1 ,7 6 0 3 ,4 3 4 ,0 0 0 5 9 7 ,1 9 3 2 6 ,2 4 9 ,0 8 5 6 ,5 4 0 ,6 7 1 4 ,0 7 3 ,4 7 4 1 ,3 9 0 ,0 7 1 1 7 ,2 8 5 ,0 4 0 5 ,3 6 4 ,7 4 7 7 1 ,4 5 9 ,7 8 3 2 7 ,0 3 0 ,2 9 8 A ra b S ta te s A lb a n ia 9 7 ,0 0 0 3 3 ,7 7 7 9 7 ,0 0 0 3 3 ,7 7 7 Ira q 4 2 ,0 0 0 1 7 ,6 3 4 7 5 0 ,0 0 0 2 5 4 ,8 8 5 7 9 2 ,0 0 0 2 7 2 ,5 1 9 K a za k sta n 1 0 ,0 0 0 7 ,0 0 0 1 0 ,0 0 0 7 ,0 0 0 K o so v o 1 0 0 ,0 0 0 3 1 ,6 3 5 1 0 0 ,0 0 0 3 1 ,6 3 5 K y rg y zsta n 6 0 ,0 0 0 2 3 ,6 7 0 6 0 ,0 0 0 2 3 ,6 7 0 M o ro cco 1 8 5 ,0 4 0 6 1 ,5 0 3 1 8 5 ,0 4 0 6 1 ,5 0 3 O m a n 1 5 0 ,0 0 0 5 0 ,8 0 4 1 5 0 ,0 0 0 5 0 ,8 0 4 P a le stin e 7 ,2 0 0 2 ,6 7 7 4 9 6 ,2 0 0 1 7 7 ,4 4 1 5 0 3 ,4 0 0 1 8 0 ,1 1 9 S u d a n 6 ,2 4 0 6 ,0 2 2 - - 8 5 ,5 0 0 3 0 ,4 5 0 9 1 ,7 4 0 3 6 ,4 7 2 S y ria n A ra b R e p u b lic 6 7 5 ,0 0 3 2 2 2 ,6 7 1 6 7 5 ,0 0 3 2 2 2 ,6 7 1 T a jik ista n 1 ,1 2 9 ,8 0 0 3 7 5 ,5 8 3 1 ,1 2 9 ,8 0 0 3 7 5 ,5 8 3 T u rk m e n ista n 5 0 ,0 0 0 1 8 ,4 9 5 5 0 ,0 0 0 1 8 ,4 9 5 U k ra in e 1 ,7 8 6 ,3 2 0 5 1 0 ,3 3 5 1 ,7 8 6 ,3 2 0 5 1 0 ,3 3 5 U zb e k ista n 1 ,1 2 1 ,2 5 3 3 9 9 ,2 9 2 1 ,1 2 1 ,2 5 3 3 9 9 ,2 9 2 Y e m e n 9 0 4 ,0 0 0 2 1 1 ,8 5 0 4 0 4 ,0 0 0 5 4 ,5 4 0 3 ,0 6 6 ,0 0 0 1 ,1 0 2 ,3 5 7 4 ,3 7 4 ,0 0 0 1 ,3 6 8 ,7 4 7 A ra b S ta te s T o ta l - - 2 4 0 ,4 8 0 8 7 ,8 3 6 9 0 4 ,0 0 0 2 1 1 ,8 5 0 4 0 4 ,0 0 0 5 4 ,5 4 0 - - 7 ,7 9 0 ,7 5 6 2 ,7 2 8 ,0 6 0 1 ,7 8 6 ,3 2 0 5 1 0 ,3 3 5 1 1 ,1 2 5 ,5 5 6 3 ,5 9 2 ,6 2 2 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 1 A n n e x - 3 D e stin a tio n C o u n trie s: A sia D F ID IP P F K F W M S I P S I U N F P A U S A ID T o ta l Q u a n tity T o ta l A m o u n t in C o u n try T a b le 3 : O ra l C o n tra ce p tiv e s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ A n tig u a a n d B a rb u d a 5 ,7 4 0 2 ,0 0 3 5 ,7 4 0 2 ,0 0 3 A ru b a 4 8 0 ,6 0 0 1 ,7 5 0 4 8 0 ,6 0 0 1 ,7 5 0 B a h a m a s 5 ,0 4 0 1 ,5 4 6 5 ,0 4 0 1 ,5 4 6 B a rb a d o s 3 ,6 0 0 1 ,2 0 5 2 8 ,6 0 2 9 ,5 3 4 3 2 ,2 0 2 1 0 ,7 3 9 B e lize 2 ,1 6 0 7 1 1 - - 2 ,1 6 0 7 1 1 B o liv ia - - - - 2 2 2 ,5 7 0 7 1 ,2 2 5 2 2 2 ,5 7 0 7 1 ,2 2 5 C h ile 2 5 ,9 2 0 8 ,5 2 8 2 5 ,9 2 0 8 ,5 2 8 C o sta R ica - - - - 7 2 0 2 4 0 7 2 0 2 4 0 D o m in ica n R e p u b lic 7 ,4 4 0 2 ,3 4 2 9 3 0 ,0 0 0 2 9 4 ,2 0 6 - - 9 3 7 ,4 4 0 2 9 6 ,5 4 7 E cu a d o r 2 ,7 2 9 ,5 0 0 9 5 8 ,9 8 1 2 ,7 2 9 ,5 0 0 9 5 8 ,9 8 1 E l S a lv a d o r 2 ,3 5 8 ,7 8 0 2 4 ,1 3 4 - - - - 1 9 8 ,1 0 0 7 1 ,5 3 1 2 ,5 5 6 ,8 8 0 9 5 ,6 6 5 G a m m o l - B e lg iu m 4 ,3 2 0 1 ,4 2 1 4 ,3 2 0 1 ,4 2 1 G re n a d a 2 4 3 ,2 8 0 2 ,1 2 3 2 4 3 ,2 8 0 2 ,1 2 3 G u a te m a la - - - - 4 0 ,0 0 0 1 4 ,4 0 0 5 2 0 ,2 2 4 1 6 4 ,5 7 3 - - 5 6 0 ,2 2 4 1 7 8 ,9 7 3 H a iti 3 3 ,0 4 8 1 1 ,0 1 6 8 7 0 ,0 0 0 2 8 0 ,8 5 9 9 0 3 ,0 4 8 2 9 1 ,8 7 5 H o n d u ra s 1 2 5 ,0 4 0 4 1 ,1 3 8 - - - 2 1 5 ,0 0 1 2 6 7 ,3 5 1 - - 3 4 0 ,0 4 1 3 0 8 ,4 8 9 Ja m a ica - - 1 5 0 ,0 0 1 4 8 ,3 0 2 1 5 0 ,0 0 1 4 8 ,3 0 2 N ica ra g u a - - - - - 7 1 7 ,0 0 0 2 2 6 ,8 2 3 - - 7 1 7 ,0 0 0 2 2 6 ,8 2 3 P a n a m a 1 ,0 0 2 2 ,1 1 0 - - - - 1 ,0 0 2 2 ,1 1 0 P a ra g u a y 5 ,4 0 0 1 ,9 3 0 1 ,6 0 0 ,0 0 0 4 6 7 ,8 4 0 1 ,0 0 0 ,0 0 0 3 0 6 ,9 0 0 - - 2 ,6 0 5 ,4 0 0 7 7 6 ,6 7 0 P e ru 1 0 ,0 8 0 3 ,3 1 6 - - - - 1 0 ,0 8 0 3 ,3 1 6 S t Lu cia 1 2 ,2 7 0 4 ,4 3 3 1 2 ,2 7 0 4 ,4 3 3 S t V in ce n t 5 ,3 4 0 1 ,8 0 4 5 ,3 4 0 1 ,8 0 4 S u rin a m e 7 7 ,7 6 0 2 5 ,6 0 3 5 0 ,0 0 1 1 6 ,6 6 7 1 2 7 ,7 6 1 4 2 ,2 7 0 U ru g u a y 2 ,1 0 0 ,0 0 0 6 7 8 ,4 5 3 2 ,1 0 0 ,0 0 0 6 7 8 ,4 5 3 La tin A m e rica a n d C a rib b e a n T o ta l - - 3 ,3 7 3 ,7 7 2 1 2 6 ,0 9 6 - - - - 1 ,6 4 0 ,0 0 0 4 8 2 ,2 4 0 8 ,8 9 4 ,7 6 7 3 ,1 2 5 ,8 0 1 8 7 0 ,0 0 0 2 8 0 ,8 5 9 1 4 ,7 7 8 ,5 3 9 4 ,0 1 4 ,9 9 6 IP P F S to ck o n H a n d 5 0 4 ,2 7 9 1 8 3 ,1 8 1 5 0 4 ,2 7 9 1 8 3 ,1 8 1 O ra l C o n tra ce p tiv e P ills T o ta l 9 ,5 8 0 ,4 0 0 2 ,5 2 5 ,7 9 5 1 5 ,2 9 0 ,5 5 5 8 0 8 ,7 6 4 2 5 ,5 2 8 ,8 8 8 1 4 ,0 6 0 ,8 9 2 3 ,8 9 3 ,0 0 2 6 6 6 ,8 4 7 3 0 ,6 3 9 ,9 7 7 7 ,7 5 4 ,5 6 9 3 8 ,3 4 8 ,5 9 2 1 3 ,0 9 0 ,2 7 7 3 8 ,6 0 1 ,1 2 0 1 2 ,2 6 3 ,9 4 7 1 6 1 ,8 8 2 ,5 3 4 5 1 ,1 7 1 ,0 9 1 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 2 * U N F P A d a ta in clu d e s th ird p a rty p ro cu re m e n ts U N F P A U S A ID T o ta l Q u a n tity T o ta l A m o u n t in U S $ D F ID IP P F K F W M S I P S I D e stin a tio n C o u n trie s:La tin A m e rica & C a rib e e a n A n n e x - 3 C o u n try T a b le 4 : E m e rg e n cy C o n tra ce p tiv e P ills - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ B u ru n d i - - 3 0 ,0 0 0 7 ,5 0 0 3 0 ,0 0 0 7 ,5 0 0 C a m e ro o n 1 ,9 0 0 1 ,6 9 1 - - - - 1 ,9 0 0 1 ,6 9 1 C o m o ro s 2 0 0 5 0 2 0 0 5 0 C o n g o 1 ,9 2 0 1 ,7 0 9 - - 1 ,9 2 0 1 ,7 0 9 C o n g o - B ra zza v ille C o te D 'Iv o ire 7 2 0 6 4 1 - - 1 3 ,5 0 0 1 0 ,1 7 5 1 4 ,2 2 0 1 0 ,8 1 6 E q u a to ria l G u in e a 1 0 ,0 0 0 2 ,5 0 0 1 0 ,0 0 0 2 ,5 0 0 G a b o n 2 4 0 2 1 4 2 4 0 2 1 4 G u in e a -C o n a k ry 2 ,4 0 0 2 ,1 3 6 2 ,4 0 0 2 ,1 3 6 Le so th o - - - - 2 1 ,0 0 0 5 ,2 5 0 2 1 ,0 0 0 5 ,2 5 0 Lib e ria 4 0 0 3 5 6 - - - - 4 0 0 3 5 6 M a la w i 2 0 ,0 0 0 5 ,0 0 0 2 0 ,0 0 0 5 ,0 0 0 M a u ritiu s - - 1 0 ,0 0 0 2 ,5 0 0 1 0 ,0 0 0 2 ,5 0 0 N ig e ria 2 4 0 2 1 4 1 ,2 0 0 ,0 0 0 6 2 4 ,0 0 0 - - 1 ,2 0 0 ,2 4 0 6 2 4 ,2 1 4 R w a n d a 1 ,2 0 0 1 ,0 6 8 - - - - 1 ,2 0 0 1 ,0 6 8 S ie rra Le o n e 2 4 0 2 1 4 1 5 ,0 0 0 1 5 ,3 0 0 2 0 ,0 0 0 2 0 ,4 0 0 1 ,0 0 0 2 5 0 3 6 ,2 4 0 3 6 ,1 6 4 T a n za n ia 5 0 0 4 4 5 - - - - 5 0 0 4 4 5 U g a n d a 2 ,1 0 0 1 ,8 6 9 - - - - 9 0 0 ,0 0 0 2 2 5 ,0 0 0 9 0 2 ,1 0 0 2 2 6 ,8 6 9 A frica T o ta l - - 1 1 ,8 6 0 1 0 ,5 5 5 1 5 ,0 0 0 1 5 ,3 0 0 2 0 ,0 0 0 2 0 ,4 0 0 1 ,2 0 0 ,0 0 0 6 2 4 ,0 0 0 1 ,0 0 5 ,7 0 0 2 5 8 ,2 2 5 - - 2 ,2 5 2 ,5 6 0 9 2 8 ,4 8 0 B h u ta n 2 ,5 0 0 6 2 5 2 ,5 0 0 6 2 5 F iji 1 ,2 0 0 3 0 0 1 ,2 0 0 3 0 0 M o n g o lia - - 8 0 ,0 0 0 2 0 ,8 0 0 5 ,0 0 0 1 ,2 5 0 8 5 ,0 0 0 2 2 ,0 5 0 M y a n m a r - - 3 5 ,0 0 0 1 4 ,7 5 0 3 0 ,0 0 0 8 ,3 4 0 2 9 ,1 7 7 7 ,8 5 0 9 4 ,1 7 7 3 0 ,9 4 0 P a k ista n - - - - 2 1 0 ,0 0 0 5 2 ,5 0 0 2 1 0 ,0 0 0 5 2 ,5 0 0 S ri La n k a 1 0 ,0 0 0 2 ,5 0 0 1 0 ,0 0 0 2 ,5 0 0 A sia P a cific T o ta l - - - - - - 1 1 5 ,0 0 0 3 5 ,5 5 0 3 0 ,0 0 0 8 ,3 4 0 2 5 7 ,8 7 7 6 5 ,0 2 5 - - 4 0 2 ,8 7 7 1 0 8 ,9 1 5 Ira q 2 ,8 8 0 2 ,5 6 3 - - 2 ,8 8 0 2 ,5 6 3 K a za k sta n 5 ,0 0 0 1 ,2 5 0 5 ,0 0 0 1 ,2 5 0 K o so v o 3 0 ,0 0 0 7 ,5 0 0 3 0 ,0 0 0 7 ,5 0 0 P a le stin e 4 8 0 4 2 7 - - 4 8 0 4 2 7 T u rk m e n ista n 1 5 ,0 0 0 3 ,7 5 0 1 5 ,0 0 0 3 ,7 5 0 A ra b S ta te s T o ta l - - 3 ,3 6 0 2 ,9 9 0 - - - - - - 5 0 ,0 0 0 1 2 ,5 0 0 - - 5 3 ,3 6 0 1 5 ,4 9 0 A ru b a 1 0 0 8 9 1 0 0 8 9 C u b a 1 8 0 ,0 0 0 4 5 ,0 0 0 1 8 0 ,0 0 0 4 5 ,0 0 0 D o m in ica n R e p u b lic 7 2 0 6 4 1 5 0 ,0 0 0 1 2 ,5 0 0 5 0 ,7 2 0 1 3 ,1 4 1 G re n a d a 4 0 0 3 5 6 4 0 0 3 5 6 G u a te m a la - - - - 2 ,0 0 0 5 0 0 2 ,0 0 0 5 0 0 H a iti 1 6 ,0 0 0 4 ,0 0 0 1 6 ,0 0 0 4 ,0 0 0 P a ra g u a y - - 2 2 0 ,0 0 0 6 7 ,3 6 4 2 0 ,0 0 0 5 ,0 0 0 2 4 0 ,0 0 0 7 2 ,3 6 4 S t Lu cia 1 ,9 0 0 1 ,6 9 1 1 ,9 0 0 1 ,6 9 1 S t V in ce n t 2 ,7 0 0 2 ,4 0 3 2 ,7 0 0 2 ,4 0 3 U ru g u a y 6 0 ,0 0 0 1 5 ,0 0 0 6 0 ,0 0 0 1 5 ,0 0 0 La tin A m e rica a n d C a rib b e a n T o ta l - - 5 ,8 2 0 5 ,1 8 0 - - - - 2 2 0 ,0 0 0 6 7 ,3 6 4 3 2 8 ,0 0 0 8 2 ,0 0 0 - - 5 5 3 ,8 2 0 1 5 4 ,5 4 4 E m e rg e n cy C o n tra ce p tiv e T o ta l - - 2 1 ,0 4 0 1 8 ,7 2 6 1 5 ,0 0 0 1 5 ,3 0 0 1 3 5 ,0 0 0 5 5 ,9 5 0 1 ,4 5 0 ,0 0 0 6 9 9 ,7 0 4 1 ,6 4 1 ,5 7 7 4 1 7 ,7 5 0 - - 3 ,2 6 2 ,6 1 7 1 ,2 0 7 ,4 2 9 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 3 * U N F P A d a ta in clu d e s th ird p a rty p ro cu re m e n ts La tin A m e rica a n d C a rib b e a n A sia P a cific A ra b S ta te s A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A * U S A ID T o ta l Q u a n tity T o ta l A m o u n t in C o u n try T a b le 5 : In je cta b le s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ A n g o la 1 0 0 ,0 0 0 4 2 ,0 0 0 1 8 0 ,8 0 0 2 2 0 ,3 6 3 2 8 0 ,8 0 0 2 6 2 ,3 6 3 B e n in - - - 7 8 ,0 0 0 1 0 2 ,2 5 8 - - 7 8 ,0 0 0 1 0 2 ,2 5 8 C a m e ro o n - - 5 ,0 0 0 3 ,1 6 1 4 0 0 ,0 0 0 1 4 4 ,0 0 0 4 0 5 ,0 0 0 1 4 7 ,1 6 1 C a p e V e rd e 1 4 0 ,0 0 0 5 3 ,2 0 0 1 4 0 ,0 0 0 5 3 ,2 0 0 C e n tra l A frica n R e p u b lic 7 ,0 0 0 9 ,0 6 5 - - 3 3 9 ,0 9 0 2 1 3 ,1 8 8 3 4 6 ,0 9 0 2 2 2 ,2 5 3 C h a d 2 ,1 0 0 2 ,2 8 9 1 3 ,0 0 0 7 ,9 6 0 1 5 ,1 0 0 1 0 ,2 4 9 C o m o ro s 8 2 ,8 0 0 6 1 ,2 7 2 8 2 ,8 0 0 6 1 ,2 7 2 C o n g o 2 ,0 0 0 2 ,7 4 6 4 6 ,0 0 0 1 9 ,3 2 0 4 8 ,0 0 0 2 2 ,0 6 6 C o n g o , D e m o cra tic R e p u b lic o f 5 1 3 ,2 0 0 5 0 9 ,8 2 8 5 1 3 ,2 0 0 5 0 9 ,8 2 8 C o n g o , T h e D e m o cra tic R e p u b lic 3 6 ,7 0 0 4 0 ,0 0 0 2 ,8 6 0 ,0 0 0 9 7 0 ,3 5 0 2 ,8 9 6 ,7 0 0 1 ,0 1 0 ,3 5 0 C o te D 'Iv o ire 5 4 ,7 0 0 7 3 ,5 2 5 2 2 7 ,2 2 9 1 4 3 ,6 4 8 4 3 2 ,8 0 1 2 9 2 ,0 0 5 7 1 4 ,7 3 0 5 0 9 ,1 7 9 E q u a to ria l G u in e a 2 0 ,0 0 0 1 1 ,6 0 0 2 0 ,0 0 0 1 1 ,6 0 0 E ritre a 1 9 0 ,0 0 0 7 9 ,8 0 0 1 9 0 ,0 0 0 7 9 ,8 0 0 E th io p ia - - - - - - 2 ,8 0 0 ,0 0 0 2 ,9 9 0 ,2 7 6 2 ,8 0 0 ,0 0 0 2 ,9 9 0 ,2 7 6 G a b o n 1 ,0 0 0 1 ,3 7 3 1 ,0 0 0 1 ,3 7 3 G a m b ia 4 2 0 ,0 0 0 1 8 0 ,3 2 5 4 2 0 ,0 0 0 1 8 0 ,3 2 5 G h a n a - - 2 ,9 9 2 ,0 0 0 1 ,0 7 7 ,3 0 0 2 ,2 0 0 ,0 0 0 2 ,4 3 6 ,9 2 5 5 ,1 9 2 ,0 0 0 3 ,5 1 4 ,2 2 5 G u in e a 3 0 0 ,0 0 0 1 1 4 ,0 0 0 3 0 0 ,0 0 0 1 1 4 ,0 0 0 G u in e a -B issa u - - - - 4 0 ,0 0 0 1 6 ,0 0 0 4 0 ,0 0 0 1 6 ,0 0 0 G u in e a -C o n a k ry 1 3 ,3 0 0 1 4 ,4 9 6 1 3 ,3 0 0 1 4 ,4 9 6 K e n y a 7 ,7 0 0 8 ,9 0 3 - - - - 1 ,9 9 4 ,0 0 0 7 9 1 ,5 4 0 2 ,7 0 0 ,0 0 0 3 ,1 0 8 ,6 2 0 4 ,7 0 1 ,7 0 0 3 ,9 0 9 ,0 6 3 Le so th o 7 ,9 0 0 8 ,9 7 3 - - 4 2 3 ,7 0 0 1 7 6 ,7 0 6 4 3 1 ,6 0 0 1 8 5 ,6 7 9 Lib e ria 9 ,0 0 0 9 ,8 0 9 - - 9 6 ,0 0 0 4 0 ,3 2 0 1 5 6 ,0 0 0 1 9 6 ,2 0 1 2 6 1 ,0 0 0 2 4 6 ,3 3 0 M a d a g a sca r 2 ,6 0 0 3 ,5 7 0 - - - - 5 ,0 9 4 ,4 0 0 1 ,5 8 2 ,7 0 2 9 7 0 ,4 0 0 1 ,0 8 9 ,4 2 7 6 ,0 6 7 ,4 0 0 2 ,6 7 5 ,6 9 9 M a la w i - - 5 ,3 3 0 ,0 0 0 1 ,8 6 3 ,6 0 0 5 9 2 ,0 0 0 6 9 6 ,6 6 3 5 ,9 2 2 ,0 0 0 2 ,5 6 0 ,2 6 3 M a li - - 1 ,5 0 0 ,0 0 0 1 ,4 5 8 ,8 1 5 - - 1 ,1 5 2 ,3 0 0 3 9 0 ,4 2 4 2 2 6 ,8 0 0 2 7 5 ,0 1 3 2 ,8 7 9 ,1 0 0 2 ,1 2 4 ,2 5 2 M a u rita n ia 2 ,5 0 0 2 ,7 2 5 2 2 ,4 0 0 1 0 ,9 9 4 2 4 ,9 0 0 1 3 ,7 1 9 M a u ritiu s 4 0 0 4 3 6 - - 4 0 0 4 3 6 M o za m b iq u e 4 ,2 0 0 5 ,0 5 9 - - - - 1 ,0 5 2 ,8 0 0 1 ,1 7 0 ,7 9 6 1 ,0 5 7 ,0 0 0 1 ,1 7 5 ,8 5 5 N a m ib ia - - 3 8 7 ,0 5 0 1 4 8 ,8 9 7 3 8 7 ,0 5 0 1 4 8 ,8 9 7 N ig e r 1 ,5 0 0 1 ,6 3 5 2 1 9 ,2 0 0 7 8 ,9 1 2 2 2 0 ,7 0 0 8 0 ,5 4 7 N ig e ria 3 ,5 0 8 ,0 0 0 3 ,2 8 2 ,2 6 5 2 1 ,0 0 0 2 6 ,9 6 9 - - 5 ,1 1 8 ,1 0 1 2 ,5 6 6 ,4 6 4 2 ,1 1 8 ,0 0 0 2 ,3 7 0 ,2 9 2 1 0 ,7 6 5 ,1 0 1 8 ,2 4 5 ,9 9 0 R w a n d a 7 ,2 0 0 8 ,9 0 3 - - - - 1 ,0 3 2 ,8 0 0 1 ,1 6 6 ,7 9 2 1 ,0 4 0 ,0 0 0 1 ,1 7 5 ,6 9 5 S a o T o m e a n d P rin cip e 1 ,3 0 0 1 ,4 1 7 1 2 ,4 0 0 5 ,2 0 8 1 3 ,7 0 0 6 ,6 2 5 S e n e g a l - - 1 ,6 0 0 ,0 0 0 4 8 4 ,0 0 0 - - 1 ,6 0 0 ,0 0 0 4 8 4 ,0 0 0 S ie rra Le o n e 4 ,5 0 0 5 ,3 2 9 2 7 ,0 0 0 2 4 ,3 3 9 7 8 4 ,6 5 0 2 7 1 ,0 3 1 9 9 ,6 0 0 1 2 2 ,3 8 8 9 1 5 ,7 5 0 4 2 3 ,0 8 6 S w a zila n d 1 3 ,7 4 8 1 3 ,7 4 8 T a n za n ia 4 0 0 4 3 6 - - 1 ,5 0 0 ,0 0 0 4 9 5 ,0 0 0 1 7 7 ,2 0 0 2 2 2 ,8 4 6 1 ,6 7 7 ,6 0 0 7 1 8 ,2 8 2 T o g o 1 ,7 0 0 2 ,3 3 4 - - 3 9 2 ,0 0 0 1 6 3 ,6 0 4 4 0 ,0 0 0 4 8 ,4 5 5 4 3 3 ,7 0 0 2 1 4 ,3 9 3 U g a n d a 1 ,0 0 0 9 2 2 - - - - 1 ,7 3 2 ,0 0 0 5 7 3 ,3 6 0 4 ,8 1 9 ,2 0 0 5 ,5 6 0 ,0 2 8 6 ,5 5 2 ,2 0 0 6 ,1 3 4 ,3 1 0 Z a m b ia 1 2 ,1 0 0 1 5 ,3 6 9 - - - - 5 0 0 ,0 0 0 5 0 6 ,6 6 5 5 1 2 ,1 0 0 5 2 2 ,0 3 4 Z im b a b w e - - 3 6 ,0 0 0 1 5 ,1 2 0 - - 3 6 ,0 0 0 1 5 ,1 2 0 A frica T o ta l 3 ,5 0 8 ,0 0 0 3 ,2 8 2 ,2 6 5 2 0 1 ,8 0 0 2 4 6 ,2 8 5 1 ,5 0 0 ,0 0 0 1 ,4 5 8 ,8 1 5 2 7 ,0 0 0 2 4 ,3 3 9 2 3 2 ,2 2 9 1 4 6 ,8 0 9 3 4 ,3 4 7 ,8 9 3 1 3 ,0 4 6 ,2 0 8 2 0 ,1 7 8 ,8 0 0 2 2 ,6 9 1 ,5 7 8 5 9 ,9 9 5 ,7 2 2 4 0 ,8 9 6 ,2 9 9 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 4 A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A * U S A ID T o ta l Q u a n tity T o ta l A m o u n t in C o u n try T a b le 5 : In je cta b le s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ A fg h a n ista n 5 0 ,0 0 0 3 3 ,5 7 0 8 0 ,0 0 0 3 3 ,6 0 0 4 8 0 ,0 0 0 5 2 8 ,1 4 5 6 1 0 ,0 0 0 5 9 5 ,3 1 5 B a n g la d e sh - - 7 6 8 ,0 0 0 7 5 0 ,8 7 4 7 6 8 ,0 0 0 7 5 0 ,8 7 4 C a m b o d ia 3 ,4 0 0 ,0 0 0 1 ,6 5 2 ,9 7 6 1 ,1 0 1 ,2 7 0 6 9 6 ,1 9 4 1 2 4 ,5 0 0 7 6 ,1 6 0 - - 4 ,6 2 5 ,7 7 0 2 ,4 2 5 ,3 3 0 C o o k Isla n d s 8 0 0 8 7 2 8 0 0 8 7 2 E a st T im o r 1 2 0 ,6 0 0 6 0 ,9 4 2 1 2 0 ,6 0 0 6 0 ,9 4 2 In d ia 4 0 ,2 0 0 2 5 ,4 1 3 4 0 ,2 0 0 2 5 ,4 1 3 K irib a ti 1 0 0 1 0 9 1 0 0 1 0 9 M a la y sia 3 ,7 0 0 4 ,5 7 1 - - 3 ,7 0 0 4 ,5 7 1 M o n g o lia - - 5 0 0 4 4 6 1 4 4 ,0 0 0 1 0 6 ,4 0 0 1 4 4 ,5 0 0 1 0 6 ,8 4 6 M y a n m a r 1 2 ,5 0 0 1 3 ,6 2 4 - - - - 1 ,5 5 0 ,0 0 1 5 7 2 ,7 5 0 - - 1 ,5 6 2 ,5 0 1 5 8 6 ,3 7 4 N e p a l - - - - 3 2 7 ,6 0 0 3 7 4 ,7 4 9 3 2 7 ,6 0 0 3 7 4 ,7 4 9 N e p a l 1 ,1 0 0 ,0 0 0 6 8 9 ,8 1 6 1 ,1 0 0 ,0 0 0 6 8 9 ,8 1 6 P a k ista n 9 2 9 ,0 9 6 5 8 7 ,3 5 0 - - 4 0 0 ,0 0 0 2 5 2 ,8 6 9 2 ,0 2 0 ,0 0 0 1 ,0 2 9 ,7 9 0 1 ,3 4 6 ,8 0 0 1 ,3 8 2 ,7 2 0 4 ,6 9 5 ,8 9 6 3 ,2 5 2 ,7 2 9 P a p u a N e w G u in e a 5 0 0 5 4 5 1 ,1 7 8 ,0 0 0 3 8 9 ,1 0 0 - - 1 ,1 7 8 ,5 0 0 3 8 9 ,6 4 5 P h ilip p in e s 1 4 ,5 0 0 1 6 ,7 1 0 - - 6 1 0 ,0 0 0 2 0 2 ,2 0 0 6 2 4 ,5 0 0 2 1 8 ,9 1 0 S a b a h 3 ,1 0 0 3 ,6 9 0 3 ,1 0 0 3 ,6 9 0 S a m o a 5 ,0 0 0 5 ,4 5 0 5 ,0 0 0 5 ,4 5 0 S a ra w a k 8 ,1 0 0 9 ,9 3 3 8 ,1 0 0 9 ,9 3 3 S o lo m o n Isla n d s 1 0 0 1 0 9 1 0 0 1 0 9 T u v a lu 1 0 0 1 0 9 1 0 0 1 0 9 A sia P a cific T o ta l - - 4 8 ,5 0 0 5 5 ,7 2 2 5 ,4 2 9 ,0 9 6 2 ,9 3 0 ,1 4 2 5 0 ,5 0 0 3 4 ,0 1 6 1 ,5 4 1 ,4 7 0 9 7 4 ,4 7 6 5 ,8 2 7 ,1 0 1 2 ,4 7 0 ,9 4 2 2 ,9 2 2 ,4 0 0 3 ,0 3 6 ,4 8 8 1 5 ,8 1 9 ,0 6 7 9 ,5 0 1 ,7 8 7 A ra b S ta te s A lb a n ia 2 0 ,0 0 0 8 ,4 0 0 2 0 ,0 0 0 8 ,4 0 0 D jib o u ti 1 5 ,0 0 0 1 0 ,2 0 0 1 5 ,0 0 0 1 0 ,2 0 0 Ira q 3 ,3 2 5 3 ,6 2 4 2 0 0 ,0 0 0 7 2 ,0 0 0 2 0 3 ,3 2 5 7 5 ,6 2 4 K a za k h sta n 9 ,0 0 0 6 ,9 3 0 9 ,0 0 0 6 ,9 3 0 K o so v o 3 0 ,0 0 0 1 2 ,6 0 0 3 0 ,0 0 0 1 2 ,6 0 0 K y rg y zsta n - - - - M o ro cco 5 ,0 0 0 5 ,4 5 0 5 ,0 0 0 5 ,4 5 0 O m a n 4 7 ,0 0 0 3 6 ,1 9 0 4 7 ,0 0 0 3 6 ,1 9 0 P a le stin e 3 0 0 3 2 7 7 0 ,4 0 0 2 9 ,5 6 8 7 0 ,7 0 0 2 9 ,8 9 5 S u d a n 4 ,0 0 0 4 ,3 6 0 - - - - 1 7 ,4 0 0 7 ,3 0 8 2 1 ,4 0 0 1 1 ,6 6 8 S y ria n A ra b R e p u b lic 3 5 ,0 0 0 4 8 ,3 0 0 3 5 ,0 0 0 4 8 ,3 0 0 T a jik ista n 4 4 6 ,4 6 0 1 9 0 ,7 3 0 4 4 6 ,4 6 0 1 9 0 ,7 3 0 U k ra in e 5 7 ,6 0 0 6 7 ,7 9 8 5 7 ,6 0 0 6 7 ,7 9 8 U zb e k ista n 1 ,5 9 7 ,6 0 0 6 5 6 ,2 9 0 1 ,5 9 7 ,6 0 0 6 5 6 ,2 9 0 Y e m e n 1 3 0 ,0 0 0 1 1 9 ,6 2 6 - - 3 2 8 ,0 0 0 1 2 6 ,3 6 0 4 5 8 ,0 0 0 2 4 5 ,9 8 6 A ra b S ta te s T o ta l - - 1 2 ,6 2 5 1 3 ,7 6 0 1 3 0 ,0 0 0 1 1 9 ,6 2 6 - - - - 2 ,8 1 5 ,8 6 0 1 ,2 0 4 ,8 7 6 5 7 ,6 0 0 6 7 ,7 9 8 3 ,0 1 6 ,0 8 5 1 ,4 0 6 ,0 6 1 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 5 A n n e x - 3 D e stin a tio n C o u n trie s: A sia P a cific D F ID IP P F K F W M S I P S I U N F P A * U S A ID T o ta l Q u a n tity T o ta l A m o u n t in U S $ C o u n try T a b le 5 : In je cta b le s - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ A n tig u a a n d B a rb u d a 5 0 0 5 4 5 5 0 0 5 4 5 A ru b a 8 0 0 7 7 1 8 0 0 7 7 1 B a h a m a s 2 6 ,0 0 0 2 8 ,9 0 4 2 6 ,0 0 0 2 8 ,9 0 4 B a rb a d o s 2 ,0 0 0 2 ,1 8 1 4 8 ,8 0 0 2 5 ,8 0 8 5 0 ,8 0 0 2 7 ,9 8 9 B e lize 7 ,4 2 5 7 ,6 6 5 - - 7 ,4 2 5 7 ,6 6 5 B o liv ia - - - - 1 ,0 8 1 ,6 0 0 3 6 6 ,2 6 8 1 ,0 8 1 ,6 0 0 3 6 6 ,2 6 8 C h ile 7 ,0 0 0 9 ,4 3 6 7 ,0 0 0 9 ,4 3 6 C u b a 8 5 ,2 0 0 3 2 ,3 7 6 8 5 ,2 0 0 3 2 ,3 7 6 C u ra ca o 2 ,2 0 0 2 ,3 9 8 2 ,2 0 0 2 ,3 9 8 D o m in ica n R e p u b lic 3 ,5 0 0 4 ,6 6 4 9 7 0 ,0 0 0 3 3 6 ,0 0 0 - - 9 7 3 ,5 0 0 3 4 0 ,6 6 4 E l S a lv a d o r 6 9 ,1 0 0 9 0 ,0 1 0 - - 1 ,4 0 0 ,1 0 0 5 4 5 ,1 4 1 1 ,4 6 9 ,2 0 0 6 3 5 ,1 5 1 G re n a d a 1 ,6 0 0 1 ,8 5 7 1 ,6 0 0 1 ,8 5 7 G u a te m a la - - - - 1 ,5 5 9 ,2 3 0 9 4 1 ,9 1 3 - - 1 ,5 5 9 ,2 3 0 9 4 1 ,9 1 3 G u y a n a 1 ,0 0 0 1 ,1 3 6 4 9 ,2 0 0 2 0 ,6 6 4 5 0 ,2 0 0 2 1 ,8 0 0 H a iti 6 6 ,9 5 0 2 8 ,1 1 9 6 8 5 ,6 0 0 7 4 4 ,4 8 6 7 5 2 ,5 5 0 7 7 2 ,6 0 5 H o n d u ra s 1 3 5 ,2 0 0 1 4 7 ,3 5 7 - - 1 ,5 9 5 ,0 0 0 5 3 3 ,3 0 0 - - 1 ,7 3 0 ,2 0 0 6 8 0 ,6 5 7 Ja m a ica 5 ,0 0 0 5 ,4 5 0 5 0 0 ,0 0 0 1 6 2 ,7 5 0 5 0 5 ,0 0 0 1 6 8 ,2 0 0 M e x ico 4 0 ,0 0 0 5 3 ,9 2 0 - - - - 4 0 ,0 0 0 5 3 ,9 2 0 N e v is 6 0 0 8 2 4 6 0 0 8 2 4 N ica ra g u a - - - - 1 ,4 2 4 ,2 0 0 5 0 6 ,4 6 2 - - 1 ,4 2 4 ,2 0 0 5 0 6 ,4 6 2 P a n a m a 4 ,5 0 0 4 ,1 4 8 - - 1 0 4 ,0 0 0 6 6 ,6 8 0 1 0 8 ,5 0 0 7 0 ,8 2 8 P a ra g u a y 1 5 ,8 0 0 1 5 ,5 4 0 - - 7 0 0 ,0 5 0 2 3 7 ,0 3 7 - - 7 1 5 ,8 5 0 2 5 2 ,5 7 6 P e ru 3 ,2 0 0 2 ,9 5 0 - - - - 3 ,2 0 0 2 ,9 5 0 S t Lu cia 2 ,2 0 0 2 ,4 0 0 2 ,2 0 0 2 ,4 0 0 S t V in ce n t 2 0 0 2 4 6 2 0 0 2 4 6 S u rin a m e 1 3 ,0 0 0 1 4 ,1 6 9 4 ,0 0 0 1 ,6 8 0 1 7 ,0 0 0 1 5 ,8 4 9 T rin id a d a n d T o b a g o 3 ,1 0 0 3 ,3 7 9 - - 3 ,1 0 0 3 ,3 7 9 U ru g u a y 1 2 0 ,0 0 0 5 4 ,4 5 0 1 2 0 ,0 0 0 5 4 ,4 5 0 V e n e zu e la 2 ,3 0 0 2 ,2 2 1 - - 2 ,3 0 0 2 ,2 2 1 La tin A m e rica a n d C a rib b e a n T o ta l - - 3 4 6 ,2 2 5 4 0 2 ,1 7 1 - - - - - - 9 ,7 0 8 ,3 3 0 3 ,8 5 8 ,6 4 7 6 8 5 ,6 0 0 7 4 4 ,4 8 6 1 0 ,7 4 0 ,1 5 5 5 ,0 0 5 ,3 0 4 IP P F S to ck o n H a n d 1 1 2 ,6 0 0 1 5 1 ,0 6 0 1 1 2 ,6 0 0 1 5 1 ,0 6 0 In je cta b le T o ta l 3 ,5 0 8 ,0 0 0 3 ,2 8 2 ,2 6 5 7 2 1 ,7 5 0 8 6 8 ,9 9 8 7 ,0 5 9 ,0 9 6 4 ,5 0 8 ,5 8 4 7 7 ,5 0 0 5 8 ,3 5 5 1 ,7 7 3 ,6 9 9 1 ,1 2 1 ,2 8 6 5 2 ,6 9 9 ,1 8 4 2 0 ,5 8 0 ,6 7 4 2 3 ,8 4 4 ,4 0 0 2 6 ,5 4 0 ,3 5 0 8 9 ,6 8 3 ,6 2 9 5 6 ,9 6 0 ,5 1 1 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 6 * U N F P A d a ta in clu d e s th ird p a rty p ro cu re m e n ts A n n e x - 3 D e stin a tio n C o u n trie s: La tin A m e rica a n d C a rib b e a n D F ID IP P F K F W M S I P S I U N F P A * U S A ID T o ta l Q u a n tity T o ta l A m o u n t in U S $ C o u n try T a b le 6 : IU D - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ B e n in - - 9 0 0 1 ,0 3 5 3 ,5 0 0 1 ,1 3 1 - - 4 ,4 0 0 2 ,1 6 6 B u rk in a F a so 2 ,6 5 0 9 0 8 - - 1 1 ,0 0 0 4 ,0 7 0 - - 1 3 ,6 5 0 4 ,9 7 8 C a m e ro o n - - 3 ,0 0 0 1 ,3 8 0 5 ,7 5 0 1 ,7 4 9 8 ,7 5 0 3 ,1 2 9 C a p e V e rd e 1 ,0 0 0 3 0 9 1 ,0 0 0 3 0 9 C e n tra l A frica n R e p u b lic - - - - 5 ,4 7 7 1 ,6 9 2 5 ,4 7 7 1 ,6 9 2 C o n g o 1 0 0 3 4 1 ,0 0 0 3 2 3 1 ,1 0 0 3 5 7 C o n g o , D R e p u b lic 7 0 0 2 4 0 1 4 ,1 0 0 7 ,2 2 1 - - 1 4 ,8 0 0 7 ,4 6 1 C o te D 'Iv o ire 3 ,6 0 0 1 ,2 3 4 - - 4 ,0 0 0 1 ,2 3 6 7 ,6 0 0 2 ,4 7 0 E q u a to ria l G u in e a 1 ,5 0 0 3 2 8 1 ,5 0 0 3 2 8 E ritre a 3 ,0 0 0 9 6 9 3 ,0 0 0 9 6 9 E th io p ia - - - - - - 4 0 ,5 0 0 2 8 ,1 1 1 4 0 ,5 0 0 2 8 ,1 1 1 G a m b ia 1 ,5 0 0 4 8 5 1 ,5 0 0 4 8 5 G h a n a - - - - 1 5 ,6 0 0 1 0 ,7 5 1 1 5 ,6 0 0 1 0 ,7 5 1 G u in e a 2 ,0 0 0 6 4 6 2 ,0 0 0 6 4 6 G u in e a -B issa u - - - - 2 0 ,0 0 0 5 ,4 1 5 2 0 ,0 0 0 5 ,4 1 5 G u in e a -C o n a k ry - - - - K e n y a 1 ,5 4 0 8 4 0 - - 5 ,0 0 0 3 ,1 0 0 1 0 2 ,0 0 0 3 4 ,1 9 0 - - 1 0 8 ,5 4 0 3 8 ,1 3 0 M a d a g a sca r - - 1 0 ,0 0 0 3 ,2 0 0 - - 2 9 ,5 0 0 9 ,5 2 9 3 1 ,2 0 0 2 4 ,2 7 2 7 0 ,7 0 0 3 7 ,0 0 1 M a la w i 5 ,0 0 0 9 9 5 - - 5 ,0 0 0 9 9 5 M a li - - 1 ,2 0 0 6 0 0 2 1 ,6 5 0 5 ,1 0 9 4 ,8 0 0 5 ,0 8 2 2 7 ,6 5 0 1 0 ,7 9 1 M a u rita n ia - - 7 ,0 0 0 2 ,5 9 0 7 ,0 0 0 2 ,5 9 0 M a u ritiu s 3 0 0 1 0 3 - - 3 0 0 1 0 3 M o za m b iq u e 5 0 1 7 - - 3 ,3 6 7 1 ,0 8 8 - - 3 ,4 1 7 1 ,1 0 5 N ig e ria 1 ,5 0 0 5 1 4 - - - - 6 4 ,0 0 2 2 0 ,9 7 3 1 0 0 ,2 0 0 6 3 ,3 2 0 1 6 5 ,7 0 2 8 4 ,8 0 7 S e n e g a l 3 0 0 1 8 0 5 ,1 0 0 1 ,5 7 6 - - 5 ,4 0 0 1 ,7 5 6 S ie rra Le o n e - - 1 8 ,5 0 0 6 ,0 3 3 - - 1 8 ,5 0 0 6 ,0 3 3 S w a zila n d 2 ,2 6 0 6 9 8 2 ,2 6 0 6 9 8 T a n za n ia - - 2 0 ,0 0 0 1 2 ,4 0 0 1 0 ,0 0 0 1 ,9 9 0 8 2 ,2 0 0 5 6 ,2 8 6 1 1 2 ,2 0 0 7 0 ,6 7 6 T o g o - - 1 ,0 0 0 4 6 0 1 8 ,0 0 0 5 ,8 1 4 - - 1 9 ,0 0 0 6 ,2 7 4 U g a n d a - - 5 ,0 0 0 2 ,3 2 5 3 0 ,0 0 0 1 4 ,6 0 0 1 1 6 ,0 0 0 2 8 ,2 7 1 2 5 ,5 0 0 1 7 ,3 5 6 1 7 6 ,5 0 0 6 2 ,5 5 2 Z a m b ia 4 0 0 1 3 7 - - 1 ,5 0 0 5 5 5 9 ,3 0 0 6 ,7 3 3 1 1 ,2 0 0 7 ,4 2 5 Z im b a b w e 1 0 0 4 5 3 ,3 0 0 1 ,1 3 6 - - 3 ,4 0 0 1 ,1 8 1 A frica T o ta l - - 1 0 ,8 4 0 4 ,0 2 7 - - 1 5 ,4 0 0 5 ,7 5 0 7 5 ,2 0 0 4 0 ,7 9 6 4 6 6 ,9 0 6 1 3 8 ,8 9 9 3 0 9 ,3 0 0 2 1 1 ,9 1 1 8 7 7 ,6 4 6 4 0 1 ,3 8 3 A fg h a n ista n 2 4 ,0 0 0 4 ,7 7 6 - - 2 4 ,0 0 0 4 ,7 7 6 B a n g la d e sh - - 9 4 ,2 0 0 6 1 ,5 1 9 9 4 ,2 0 0 6 1 ,5 1 9 B h u ta n 5 ,0 0 0 1 ,6 1 5 5 ,0 0 0 1 ,6 1 5 C a m b o d ia 2 5 ,0 0 0 1 1 ,5 0 0 3 ,0 0 0 5 9 7 - - 2 8 ,0 0 0 1 2 ,0 9 7 E a st T im o r 1 3 ,0 0 0 3 ,0 9 6 1 3 ,0 0 0 3 ,0 9 6 F iji 2 ,3 1 0 7 1 4 2 ,3 1 0 7 1 4 In d ia 1 5 4 ,6 7 0 7 1 ,1 4 8 1 5 4 ,6 7 0 7 1 ,1 4 8 K o re a , D e m o cra tic P e o p le 's R e p 4 3 ,3 0 0 9 ,4 6 1 4 3 ,3 0 0 9 ,4 6 1 M a la y sia 2 ,0 0 0 1 ,1 1 3 - - 2 ,0 0 0 1 ,1 1 3 M o n g o lia - - 1 ,8 9 3 4 ,3 3 6 4 5 ,0 0 0 9 ,6 7 3 4 6 ,8 9 3 1 4 ,0 0 9 M y a n m a r 5 ,0 0 0 1 ,7 1 4 5 0 ,0 0 0 2 3 ,0 0 0 8 0 ,0 0 0 2 3 ,1 1 2 - - 1 3 5 ,0 0 0 4 7 ,8 2 6 N e p a l 1 0 ,0 0 0 9 ,0 0 0 - - - - 1 0 ,0 0 0 9 ,0 0 0 N e w Z e a la n d 1 0 0 3 4 1 0 0 3 4 P a k ista n 1 7 6 ,9 9 4 1 3 1 ,3 9 7 5 9 1 ,0 0 0 2 7 1 ,8 6 0 1 ,4 9 9 ,0 0 2 8 4 2 ,5 0 6 2 6 4 ,6 0 0 1 4 9 ,9 6 0 2 ,5 3 1 ,5 9 6 1 ,3 9 5 ,7 2 3 P a p u a N e w G u in e a - - 1 ,0 0 0 1 9 9 - - 1 ,0 0 0 1 9 9 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 7 A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A * U S A ID T o ta l Q u a n tity T o ta l A m o u n t in A sia P a cific C o u n try T a b le 6 : IU D - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ P h ilip p in e s 2 ,0 0 0 6 8 5 1 6 8 ,0 0 0 5 1 ,4 1 9 1 6 0 ,0 0 0 3 7 ,6 4 0 3 3 0 ,0 0 0 8 9 ,7 4 4 S a ra w a k 7 0 0 3 8 9 7 0 0 3 8 9 S o lo m o n Isla n d s 5 0 2 8 5 0 2 8 A sia P a cific T o ta l - - 9 ,8 5 0 3 ,9 6 3 1 7 6 ,9 9 4 1 3 1 ,3 9 7 1 6 9 ,8 9 3 5 5 ,7 5 5 8 3 0 ,6 7 0 3 8 6 ,5 0 8 1 ,8 7 5 ,6 1 2 9 3 3 ,3 8 8 3 5 8 ,8 0 0 2 1 1 ,4 7 9 3 ,4 2 1 ,8 1 9 1 ,7 2 2 ,4 9 1 A lb a n ia 3 ,5 0 0 1 ,2 9 5 3 ,5 0 0 1 ,2 9 5 A lg e ria 3 0 ,0 0 0 1 0 ,5 0 0 3 0 ,0 0 0 1 0 ,5 0 0 D jib o u ti 1 ,0 0 0 3 2 3 1 ,0 0 0 3 2 3 Ira q 5 ,0 0 0 1 ,7 1 4 1 0 0 ,0 0 0 3 1 ,3 0 0 1 0 5 ,0 0 0 3 3 ,0 1 4 K a za k sta n 2 0 ,0 0 0 6 ,4 6 0 2 0 ,0 0 0 6 ,4 6 0 K y rg y zsta n 9 0 ,0 0 0 2 8 ,6 2 0 9 0 ,0 0 0 2 8 ,6 2 0 M o ro cco 4 ,0 0 0 2 ,0 6 1 4 ,0 0 0 2 ,0 6 1 O m a n 5 0 0 1 6 2 5 0 0 1 6 2 P a le stin e 1 ,5 0 0 5 1 4 4 0 ,0 0 0 1 2 ,0 2 4 4 1 ,5 0 0 1 2 ,5 3 8 S u d a n - - - - 5 ,0 0 0 1 ,6 1 5 5 ,0 0 0 1 ,6 1 5 S y ria n A ra b R e p u b lic 1 0 ,0 0 0 3 ,2 3 0 1 0 ,0 0 0 3 ,2 3 0 T a jik ista n 1 0 0 9 ,5 0 0 1 0 0 9 ,5 0 0 U k ra in e 2 8 8 ,0 0 0 1 6 1 ,2 6 7 2 8 8 ,0 0 0 1 6 1 ,2 6 7 U zb e k ista n 1 ,5 8 8 ,3 5 0 4 3 2 ,7 8 1 1 ,5 8 8 ,3 5 0 4 3 2 ,7 8 1 Y e m e n 3 1 ,5 0 0 3 2 ,3 2 7 3 1 ,5 0 0 2 1 ,1 0 5 2 2 ,0 0 0 8 ,1 4 0 8 5 ,0 0 0 6 1 ,5 7 2 A ra b S ta te s T o ta l - - 1 0 ,5 0 0 4 ,2 8 9 3 1 ,5 0 0 3 2 ,3 2 7 3 1 ,5 0 0 2 1 ,1 0 5 - - 1 ,9 1 0 ,4 5 0 5 4 5 ,9 4 9 2 8 8 ,0 0 0 1 6 1 ,2 6 7 2 ,2 7 1 ,9 5 0 7 6 4 ,9 3 7 A n tig u a a n d B a rb u d a 2 0 0 6 9 2 0 0 6 9 A ru b a 5 0 2 8 5 0 2 8 B a rb a d o s 2 0 0 6 9 - - 2 0 0 6 9 B o liv ia 1 5 ,0 0 0 5 ,1 4 1 3 5 ,0 0 0 1 0 ,8 1 5 5 0 ,0 0 0 1 5 ,9 5 6 C u b a 5 3 ,0 0 0 1 8 ,5 5 0 5 3 ,0 0 0 1 8 ,5 5 0 C u ra ca o 3 5 0 1 2 0 3 5 0 1 2 0 D o m in ica n R e p u b lic 1 0 0 3 4 - - - - 1 0 0 3 4 E cu a d o r 1 1 2 ,5 0 0 3 9 ,3 7 5 1 1 2 ,5 0 0 3 9 ,3 7 5 E l S a lv a d o r 3 0 0 1 0 3 2 5 ,0 0 0 1 5 ,5 0 0 1 ,5 0 0 5 5 5 2 6 ,8 0 0 1 6 ,1 5 8 G u a te m a la - - 2 0 ,0 0 0 1 2 ,4 0 0 9 ,0 0 0 3 ,3 3 0 - - 2 9 ,0 0 0 1 5 ,7 3 0 G u y a n a - - 2 ,5 0 0 9 2 5 2 ,5 0 0 9 2 5 H o n d u ra s 9 ,6 5 0 3 ,3 0 7 - - 2 1 ,0 0 0 7 ,7 7 0 - - 3 0 ,6 5 0 1 1 ,0 7 7 Ja m a ica - - 2 ,4 0 0 8 8 8 2 ,4 0 0 8 8 8 M e x ico 1 5 ,2 0 0 5 ,2 1 1 - - - - 1 5 ,2 0 0 5 ,2 1 1 N e v is 5 0 1 7 5 0 1 7 N ica ra g u a 5 ,0 0 0 1 ,7 1 4 3 0 ,0 0 0 1 8 ,6 0 0 1 2 ,6 0 0 4 ,3 8 1 - - 4 7 ,6 0 0 2 4 ,6 9 5 P a n a m a - - - - 3 ,3 6 0 1 ,2 4 3 3 ,3 6 0 1 ,2 4 3 P a ra g u a y - - - - 2 5 ,2 0 0 9 ,3 2 4 - - 2 5 ,2 0 0 9 ,3 2 4 P e ru - - - - 1 2 ,0 0 0 7 ,0 9 1 1 2 ,0 0 0 7 ,0 9 1 S t Lu cia 4 0 0 1 3 7 4 0 0 1 3 7 S t V in ce n t 5 0 1 7 5 0 1 7 S u rin a m e 4 5 0 1 5 4 - - 4 5 0 1 5 4 U ru g u a y 2 0 ,0 0 0 6 ,1 8 0 2 0 ,0 0 0 6 ,1 8 0 V e n e zu e la 6 ,5 5 0 5 ,1 1 0 - - 6 ,5 5 0 5 ,1 1 0 La tin A m e rica a n d C a rib b e a n T o ta l - - 5 3 ,5 5 0 2 1 ,2 2 8 - - - - 7 5 ,0 0 0 4 6 ,5 0 0 2 9 8 ,0 6 0 1 0 3 ,3 3 7 1 2 ,0 0 0 7 ,0 9 1 4 3 8 ,6 1 0 1 7 8 ,1 5 6 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 8 A ra b S ta te s La tin A m e rica a n d C a rib b e a n A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A * U S A ID T o ta l Q u a n tity T o ta l A m o u n t in U S $ C o u n try T a b le 6 : IU D - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ IP P F 8 9 ,0 0 0 2 8 ,3 0 2 8 9 ,0 0 0 2 8 ,3 0 2 IP P F S to ck o n H a n d 1 9 ,4 0 0 7 ,8 3 9 1 9 ,4 0 0 7 ,8 3 9 O T H E R S T o ta l - - 1 9 ,4 0 0 7 ,8 3 9 - - - - - - 8 9 ,0 0 0 2 8 ,3 0 2 - - 1 0 8 ,4 0 0 3 6 ,1 4 1 IU D S T o ta l - - 1 2 3 ,5 4 0 4 9 ,1 8 4 2 0 8 ,4 9 4 1 6 3 ,7 2 5 2 1 6 ,7 9 3 8 2 ,6 1 0 9 8 0 ,8 7 0 4 7 3 ,8 0 4 4 ,6 4 0 ,0 2 8 1 ,7 4 9 ,8 7 5 9 6 8 ,1 0 0 5 9 1 ,7 4 8 7 ,1 1 8 ,4 2 5 3 ,1 0 3 ,1 0 7 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 4 9 * U N F P A d a ta in clu d e s th ird p a rty p ro cu re m e n ts A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A U S A ID T o ta l Q u a n tity T o ta l A m o u n t in C o u n try T a b le 7 : Im p la n t - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ A n g o la 5 0 0 1 0 ,5 0 0 - - 5 0 0 1 0 ,5 0 0 B e n in - - 7 ,4 0 0 1 8 8 ,6 4 2 2 7 ,8 0 0 5 8 3 ,8 0 0 2 ,0 0 0 4 6 ,0 5 8 3 7 ,2 0 0 8 1 8 ,5 0 0 B u rk in a F a so - - 2 ,0 5 0 1 6 ,6 1 7 4 8 ,6 0 0 1 ,0 6 0 ,6 0 0 1 2 ,0 0 0 2 7 0 ,7 6 2 6 2 ,6 5 0 1 ,3 4 7 ,9 7 9 B u ru n d i 3 0 0 9 ,2 5 0 6 0 ,0 0 0 1 ,3 0 0 ,0 0 0 - - 6 0 ,3 0 0 1 ,3 0 9 ,2 5 0 C a m e ro o n 1 0 0 3 ,0 8 3 1 0 ,0 0 0 2 5 0 ,8 5 2 1 0 ,1 0 0 2 5 2 ,1 0 0 2 0 ,2 0 0 5 0 6 ,0 3 5 C e n tra l A frica n R e p u b lic 5 0 1 ,5 4 2 - - - - 5 0 1 ,5 4 2 C h a d 5 0 1 ,5 4 2 1 ,0 0 0 2 2 ,2 0 0 1 ,0 5 0 2 3 ,7 4 2 C o n g o 2 0 6 1 7 5 0 0 1 0 ,5 0 0 5 2 0 1 1 ,1 1 7 C o te D 'Iv o ire - - - - 7 ,8 0 0 1 9 5 ,0 0 0 7 ,8 0 0 1 9 5 ,0 0 0 E ritre a 1 ,0 0 0 2 1 ,0 0 0 1 ,0 0 0 2 1 ,0 0 0 E th io p ia 1 ,6 0 0 4 5 ,7 7 1 - - 2 6 0 ,0 0 0 5 ,0 9 6 ,0 0 0 6 0 ,0 0 0 1 ,3 5 0 ,1 0 1 3 2 1 ,6 0 0 6 ,4 9 1 ,8 7 2 G a m b ia 1 0 0 2 ,1 0 0 1 0 0 2 ,1 0 0 G h a n a 3 1 0 9 ,5 5 8 1 7 ,9 0 0 4 0 1 ,5 0 0 1 5 ,0 0 0 3 3 5 ,4 0 6 3 3 ,2 1 0 7 4 6 ,4 6 4 G u in e a 1 ,0 0 0 2 1 ,0 0 0 1 ,0 0 0 2 1 ,0 0 0 G u in e a -B issa u - - - - 7 ,5 0 0 1 6 7 ,5 0 0 7 ,5 0 0 1 6 7 ,5 0 0 G u in e a -C o n a k ry 3 0 9 2 5 3 0 9 2 5 K e n y a - - 9 5 0 8 ,4 3 6 5 ,9 0 0 1 4 9 ,7 5 6 7 5 ,0 0 0 1 ,5 7 5 ,0 0 0 - - 8 1 ,8 5 0 1 ,7 3 3 ,1 9 2 Lib e ria - - - - 1 ,0 0 0 2 1 ,0 0 0 3 0 0 8 ,1 1 5 1 ,3 0 0 2 9 ,1 1 5 M a d a g a sca r - - 3 ,7 0 0 3 4 ,4 9 9 3 7 ,0 0 8 7 3 3 ,6 9 4 - - 4 0 ,7 0 8 7 6 8 ,1 9 3 M a la w i 1 ,5 0 0 3 1 ,5 0 0 3 0 ,0 0 0 6 6 9 ,9 1 7 3 1 ,5 0 0 7 0 1 ,4 1 7 M a li - - 6 ,0 0 0 1 5 8 ,9 3 8 6 0 ,7 0 0 1 ,2 7 3 ,0 2 0 7 ,4 0 0 1 6 6 ,7 9 5 7 4 ,1 0 0 1 ,5 9 8 ,7 5 3 M a u rita n ia - - 2 ,5 0 0 5 2 ,5 0 0 2 ,5 0 0 5 2 ,5 0 0 N ig e r 3 0 0 9 ,2 5 0 9 ,3 0 0 1 9 5 ,3 0 0 9 ,6 0 0 2 0 4 ,5 5 0 N ig e ria 5 0 1 ,5 4 2 5 ,3 5 2 9 7 ,4 2 8 - - 2 7 ,6 0 1 5 5 9 ,9 0 7 2 2 ,0 0 0 4 9 2 ,2 5 1 5 5 ,0 0 3 1 ,1 5 1 ,1 2 8 S e n e g a l 3 ,6 0 0 7 0 ,1 6 4 3 ,7 0 0 9 2 ,5 0 0 2 7 ,1 0 0 6 1 2 ,0 0 8 3 4 ,4 0 0 7 7 4 ,6 7 2 S ie rra Le o n e 2 0 6 1 7 1 2 ,0 0 0 1 0 3 ,0 1 0 4 3 ,5 0 0 9 3 3 ,5 0 0 - - 5 5 ,5 2 0 1 ,0 3 7 ,1 2 7 S w a zila n d 2 ,6 0 0 6 5 ,0 0 0 2 ,6 0 0 6 5 ,0 0 0 T a n za n ia - - 2 5 ,0 0 0 6 5 9 ,1 3 7 5 0 ,6 0 0 1 ,0 1 5 ,0 0 0 5 0 ,0 0 0 1 ,1 1 5 ,4 8 1 1 2 5 ,6 0 0 2 ,7 8 9 ,6 1 8 T o g o 6 0 1 ,8 5 0 4 ,0 0 0 1 0 0 ,3 4 1 5 ,0 0 0 1 0 5 ,0 0 0 1 3 ,0 0 0 2 9 0 ,9 4 6 2 2 ,0 6 0 4 9 8 ,1 3 7 U g a n d a - - 2 ,0 0 0 3 8 ,9 8 4 7 ,0 0 0 1 3 5 ,8 0 0 1 1 4 ,2 0 0 2 ,2 6 2 ,4 0 0 4 0 ,4 0 0 9 7 5 ,8 9 7 1 6 3 ,6 0 0 3 ,4 1 3 ,0 8 1 Z a m b ia - - 1 2 ,0 0 0 1 0 6 ,5 6 0 3 6 ,3 0 0 8 5 8 ,0 0 0 5 2 ,5 0 0 1 ,1 7 6 ,4 6 3 1 0 0 ,8 0 0 2 ,1 4 1 ,0 2 3 Z im b a b w e 1 0 ,8 0 0 2 2 6 ,8 0 0 3 8 ,0 0 0 8 4 8 ,3 9 5 4 8 ,8 0 0 1 ,0 7 5 ,1 9 5 Z im b a b w e 2 0 ,6 0 0 4 9 6 ,3 1 9 2 0 ,6 0 0 4 9 6 ,3 1 9 A frica T o ta l 2 0 ,6 0 0 4 9 6 ,3 1 9 2 ,8 9 0 8 5 ,5 4 4 - - 2 5 ,9 5 2 3 3 4 ,6 4 0 8 1 ,0 0 0 1 ,7 8 4 ,5 2 4 9 2 5 ,1 0 9 1 9 ,1 4 3 ,9 2 1 3 6 9 ,7 0 0 8 ,3 5 8 ,5 9 5 1 ,4 2 5 ,2 5 1 3 0 ,2 0 3 ,5 4 3 A sia P a cific C a m b o d ia - - 2 ,0 0 0 4 2 ,0 0 0 - - 2 ,0 0 0 4 2 ,0 0 0 C o o k Isla n d s 6 0 1 ,8 5 0 6 0 1 ,8 5 0 E a st T im o r 5 ,6 0 0 1 3 4 ,0 0 0 5 ,6 0 0 1 3 4 ,0 0 0 F iji 7 0 0 1 7 ,5 0 0 7 0 0 1 7 ,5 0 0 M o n g o lia 3 0 0 9 ,2 5 0 - - 3 0 0 9 ,2 5 0 N e p a l - - 4 ,0 0 0 8 4 ,0 0 0 8 ,5 0 0 1 8 9 ,5 5 5 1 2 ,5 0 0 2 7 3 ,5 5 5 P a k ista n 8 ,4 0 0 4 7 ,1 6 1 - - - - - - 8 ,4 0 0 4 7 ,1 6 1 P a p u a N e w G u in e a - - 8 0 0 1 6 ,8 0 0 - - 8 0 0 1 6 ,8 0 0 P h ilip p in e s - - - - 1 ,0 0 0 1 9 ,6 0 0 1 ,0 0 0 1 9 ,6 0 0 S ri La n k a 1 5 ,0 0 0 3 1 5 ,0 0 0 1 5 ,0 0 0 3 1 5 ,0 0 0 T u v a lu 2 0 6 1 7 2 0 6 1 7 A sia P a cific T o ta l - - 3 8 0 1 1 ,7 1 6 - - 8 ,4 0 0 4 7 ,1 6 1 - - 2 9 ,1 0 0 6 2 8 ,9 0 0 8 ,5 0 0 1 8 9 ,5 5 5 4 6 ,3 8 0 8 7 7 ,3 3 2 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 5 0 U S A ID T o ta l Q u a n tity T o ta l A m o u n t in A n n e x - 3 D e stin a tio n C o u n trie s: A frica D F ID IP P F K F W M S I P S I U N F P A * C o u n try T a b le 7 : Im p la n t - D o n o rs, C o m m o d itie s & V a lu e s Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ Q u a n tity A m o u n t U S $ D jib o u ti 5 0 0 1 0 ,5 0 0 5 0 0 1 0 ,5 0 0 S u d a n - - 1 ,8 2 0 1 9 ,5 3 7 - - 5 ,0 0 0 1 0 5 ,0 0 0 6 ,8 2 0 1 2 4 ,5 3 7 T a jik ista n 1 7 ,7 0 0 3 7 3 ,3 8 0 1 7 ,7 0 0 3 7 3 ,3 8 0 Y e m e n 3 ,2 5 1 6 3 ,8 5 0 3 ,2 5 1 6 3 ,8 5 0 A ra b S ta te s T o ta l - - - - - - 1 ,8 2 0 1 9 ,5 3 7 - - 2 6 ,4 5 1 5 5 2 ,7 3 0 - - 2 8 ,2 7 1 5 7 2 ,2 6 7 B a h a m a s 2 0 6 1 7 2 0 6 1 7 B o liv ia 9 0 0 2 7 ,7 4 9 5 0 4 4 4 - - 9 5 0 2 8 ,1 9 3 C o lo m b ia 4 ,3 0 0 9 0 ,3 0 0 4 ,3 0 0 9 0 ,3 0 0 C u b a 8 0 0 1 6 ,8 0 0 8 0 0 1 6 ,8 0 0 D o m in ica n R e p u b lic - - 3 ,0 0 8 5 8 ,9 5 7 - - 3 ,0 0 8 5 8 ,9 5 7 E cu a d o r 2 0 ,0 0 0 4 2 0 ,0 0 0 2 0 ,0 0 0 4 2 0 ,0 0 0 E l S a lv a d o r 3 9 0 1 2 ,0 2 4 - - - - 3 9 0 1 2 ,0 2 4 G u a te m a la - - - - 2 ,0 0 0 4 2 ,0 0 0 5 0 0 1 1 ,7 6 5 2 ,5 0 0 5 3 ,7 6 5 H a iti - - 1 4 ,2 0 0 3 1 6 ,7 9 5 1 4 ,2 0 0 3 1 6 ,7 9 5 Ja m a ica 2 6 0 8 ,0 1 6 1 ,5 0 0 3 7 ,5 0 0 1 ,7 6 0 4 5 ,5 1 6 P P F A La tin A m e rica 1 5 4 6 2 1 5 4 6 2 La tin A m e rica a n d C a rib b e a n T o ta l - - 1 ,5 8 5 4 8 ,8 6 9 - - 5 0 4 4 4 - - 3 1 ,6 0 8 6 6 5 ,5 5 7 1 4 ,7 0 0 3 2 8 ,5 6 0 4 7 ,9 4 3 1 ,0 4 3 ,4 3 0 O T H E R S IP P F 1 3 ,7 0 0 2 8 7 ,7 0 0 1 3 ,7 0 0 2 8 7 ,7 0 0 O T H E R S T o ta l - - - - - - - - - - 1 3 ,7 0 0 2 8 7 ,7 0 0 - - 1 3 ,7 0 0 2 8 7 ,7 0 0 Im p la n t T o ta l 2 0 ,6 0 0 4 9 6 ,3 1 9 4 ,8 5 5 1 4 6 ,1 2 9 - - 3 6 ,2 2 2 4 0 1 ,7 8 2 8 1 ,0 0 0 1 ,7 8 4 ,5 2 4 1 ,0 2 5 ,9 6 8 2 1 ,2 7 8 ,8 0 8 3 9 2 ,9 0 0 8 ,8 7 6 ,7 1 0 1 ,5 6 1 ,5 4 5 3 2 ,9 8 4 ,2 7 2 D o n o r S u p p o rt fo r C o n tra ce p tiv e s a n d C o n d o m s fo r F a m ily P la n n in g a n d S T I/H IV P re v e n tio n 5 1 * U N F P A d a ta in clu d e s th ird p a rty p ro cu re m e n ts La tin A m e rica a n d C a rib b e a n A n n e x - 3 D e stin a tio n C o u n trie s: A ra b D F ID IP P F T o ta l Q u a n tity T o ta l A m o u n t in K F W M S I P S I U N F P A U S A ID

View the publication